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Since the award of the Nobel Prize for the discovery that endothelium-derived relaxing 
factor is nitric oxide, there has been an enormous amount of research into its role in other 
physiological processes.  Nitric oxide has been shown to be involved in neurotransmission, 
respiration and fighting infection, among many other functions. While nitric oxide is essential to 
life, its overproduction can be deadly.  For example, toxic shock results from overproduction of 
nitric oxide during infection and can cause a fatal drop in blood pressure. Since many of nitric 
oxide’s biological functions involve iron complexes, our initial goals were to investigate iron 
complexes that might be used as nitric oxide scavengers.  
 Since nitric oxide is also inhibits the growth of certain types of tumors, we are 
interested in developing ruthenium nitrosyl complexes that can transport nitric oxide to a tumor 
site and release NO photolytically. This document describes the preparation and characterization 
of several bis-carboxamido bis-pyridyl and bis-carboxamido bis-pyrazyl ligands.  The 
deprotonated carboxamido group is expected to activate the RuNO moiety to photolytic loss of 
nitric oxide and then stabilize the ruthenium-solvent complex that remains after photolysis. The 
pyridyl/pyrazyl groups will enforce chelation.  Systematic variation of the ligand backbone will 
provide insight into the factors that govern photolytic loss of nitric oxide. Characterization of 
some of the respective ruthenium nitrosyl complexes is discussed. 
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1.0  GENERAL INTRODUCTION       
1.1 BACKGROUND RESEARCH 
This introduction provides a background for the research discussed in this document.  Much 
additional early work, also well directed toward current research goals, is reviewed in the 
appendix.  
It is well established that the nitrosyl moiety, whether NO+, NO•, or NO−, is sensitive to 
the nature of the central metal and to the coordination environment,1-4 and that the nitrosyl group 
exerts an influence on the reactivity of other ligands.4-9  However, the factors that control nitrosyl 
behavior are incompletely understood.  As a step toward designing ruthenium nitrosyl 
compounds intended for use in photodynamic therapy10-12 and for use as antiviral agents,13 we 
have prepared some ligands to  help elucidate effects of the coordination environment on 
ruthenium-bound NO. 
Related studies of ruthenium nitrosyl complexes include [Ru(NO+)]3+ and 
[RuII(NO+)Cl]2+ coordinated to N-(hydroxyethyl)ethylenediamine triacetate (hedta3-),14,15 
bipyridine,16,17 dipyridylamine,18,19 imidazole donors,20 peptide ligands such as diglycylhistidine 
and gly-gly-gly = triglycine,21 the π-donating macrocycle dioxocyclam22 (dioxocyclam = 
1,4,8,11-tetraazacylcotetradecane-5,7-dione), methylated biimidazole16 donors and the antitumor 
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agent bleomycin.23 Studies that have lead to the current strategy of using tetradentate π-donors to 
facilitate photolytic loss of NO• are reviewed briefly. 
      The investigation of ruthenium nitrosyl polyaminopolycarboxylates, including 
[RuII(NO+)(hedta3-)]  [(hedta3- = N-(hydroxyethyl)ethylenediaminetriacetate)], provided the first 
comparison of RuIINO+, RuIINO•, and RuIINO¯ complexes that have identical secondary ligand 
fields and a constant oxidation state for the central metal.14 The thorough investigation of the 
[Ru(NO)]3+ complex of bleomycin revealed that bleomycin’s coordination preference depends 
on the metal’s dn count, as well as on the π-acceptor nature and the hydrogen bonding capacity of  
NO+ or its replacement. The study also illustrated that ruthenium nitrosyl agents can be tuned for 
cell selectivity.23,24  
Studies of the different structural isomers15 of [RuII(NO+)(hedta)(H2O)] showed that two 
nitrogen π-donating ligands cis to the nitrosyl group push electron density onto the nitrosyl 
moiety. Increased electron density on the nitrosyl group is evidenced by a decrease in the NO 
stretching frequency, an effect which has been correlated with a propensity to lose NO by 
photolysis.13,24-27  Because amido groups also facilitate cell transport,28-33 peptides such as  
triglycine (gly-gly-gly) and  diglycylhistidine (gly-gly-his) were investigated as amido donor 
ligands.21 Gly-gly-gly coordination to [Ru(NO)Cl3(H2O)2] occurred through the terminal amine 
and the amido group only at pH  = 8.22.  With gly-gly-his, 70 % of the coordination was due to 
the histidyl group, 20 % was due to the histidyl and amido chelate, and 10 % coordinated 
through the amine and the amido group at the gly-gly end of gly-gly-his.  One conclusion from 
the peptide investigations was that, even though peptides are desirable ligands that can be 
tailored to target specific cell types, the ligands’ failure to chelate fully under physiological 
conditions diminishes their potential as ligands for NO transport. If peptides are to be used as 
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transporter ligands, they may have to be connected to synthetic chelates at the Ru(NO) center via 
biocompatible linkers. 
Since multiple coordination to peptides was found to be disfavored below pH = 7, the 
viability of the dioxocyclam (dioxocyclam = 1,4,8,11 -tetraazacyclotetradecane-5,7-dione) 
ligand22 was investigated. The hypothesis was that the macrocyclic dioxocyclam ligand would 
enforce the desired bis-amine/bis-amide chelation. The [Ru(NO)(dioxocyclam)Cl] compound 
induced lower νNO (1845 cm-1) than did the tetra-amino [Ru(NO)(cyclam)]2+ (νNO = 1875 cm-1)34 
(cyclam = 1,4,8,11- tetraazacyclotetradecane),  an effect that illustrates the significant shift of 
electron density to NO by the amido groups in dioxocyclam. This study provided additional 
evidence that amido ligands activate the nitrosyl group.  The dioxocyclam complex, like that of 
cyclam, exhibits slow release of NO.  The intent was to derivatize dioxocyclam at the methylene 
carbon between the two carbonyl groups with side chains that can increase the solubility and 
recognition; however, other strategies were adopted because the dioxocyclam ligand was too 
costly for use on a large scale.  
Based on results obtained in an ESI-MS investigation of  cis-[Ru(NO)Cl(bpy)2]2+, it was 
concluded that π-acceptor ligands, by competing with NO+ for electron density, can weaken the 
Ru-NO bond, and assist the thermal and gas phase dissociation of NO•. On the other hand, π-
donor ligands inhibit thermal and gas phase reactions by strengthening backbonding from RuII to 
NO.24 The opposite applies to photolytic loss of NO•; π-donor ligands may facilitate photolytic 
loss of NO• while π-acceptor ligands, such as N-heterocyclic ligands, inhibit photolytic loss of 
NO• from ruthenium nitrosyl complexes  because they can exhibit MLCT to the N-heterocyclic 
π-acceptor and ligand field (LF) excitations which are at lower energy than the MLCT-to-NO+ 
state.24,26,27,35  
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 Some observations from the studies described illustrate the rationale behind our selection 
of ligands and the use of ruthenium as the central metal ion. Ruthenium is the transition metal of 
choice for nitrosyl compounds designed for photodynamic therapy27 because ruthenium 
complexes are known to accumulate in tumors36-42 and because the strength of the Ru-NO bond4 
increases the probability that the complex will survive under physiological conditions. Nitrosyl 
photolability may be controlled by altering the π-donor/π-acceptor character of the ligand set. As 
one of the best π-donating groups, a deprotonated amido functionality should activate the 
nitrosyl moiety to photolabilization27  by pushing electron density onto the nitrosyl group.  The 
amido group’s inclination toward water solubility and biocompatibility make chelated amido 
donors good ligands for transporting the ruthenium nitrosyl moiety through biological 
environments.28-33  Our focus was on developing ruthenium nitrosyl complexes bearing 
tetradentate, bis-pyridyl/bis-carboxamido ligands, bis-pyrazyl/bis-carboxamido ligands and 
mixed carboxamido/phenolato ligands. The pyridyl/pyrazyl ligands exert a chelate 
effect27,28,32,43,44while the strong π-donating bis-amido/bis-phenolato donors should activate the 
RuII(NO+) moiety toward photolysis, then stabilize the RuIII-solvent complex formed upon 
photolysis.3,27,45-48 Although the ligands described here were designed to examine the possibility 
of tuning the nitrosyl’s photolability by modifications of the ligand set in the equatorial plane, we 
have also investigated ligands that will place a π-donor in a position trans to the nitrosyl group.   
It is well known that ligands trans to the nitrosyl group influence the behavior of the NO group 
by direct interaction with the π* orbitals of the NO group through the metal center.35,49-55  
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1.2 ENEMARK-FELTHAM NOTATI ON 
Because early explanations for the behavior of metal nitrosyl complexes, which were based 
solely upon the oxidation state of the nitrosyl group, were inadequate, Enemark and Feltham 
developed a formalism that considers the Ru-NO moiety as a unit. Since the ruthenium nitrosyl 
complexes described in this document are formally of the {RuNO}6 type in the Enemark-
Feltham notation, this section will summarize the development and application of the Enemark-
Feltham notation.5,56-60 
 In the 1930’s Sidgwick recognized that, in bonding interactions with transition metals, 
nitric oxide, NO•, could lose an electron to form NO+ or gain an electron to form NO−.  The 
valence bond structure of NO+ has triple bond character (sp hybridized, linear), so Sidgwick 
proposed that NO+ complexes would exhibit a linear MNO group.  The valence bond structure 
for NO− has double bond character (sp2 hybridized, 120° bond angle), thus it was assumed that 
NO− complexes would exhibit a bent MNO bond.61,62  In fact, the first linear MNO complexes 
characterized in the 1930’s were NO+;  later, in the 1960’s, bent MNO− groups were also 
characterized.63,64  The available experimental evidence seemed to indicate that the charge on the 
NO group determined the MNO bond angle.  After more transition metal nitrosyl complexes 
were characterized, it became clear that something other than the charge on NO determined the 
MNO bond angle.  Recognizing that metal nitrosyl complexes are highly covalent, Enemark and 
Feltham developed a system that accounts for the MNO angle and the reactivity of MNO 
complexes based upon molecular orbital correlation diagrams.5 
 The Enemark-Feltham approach treats each MNO group as a covalently bound entity 
which is sensitive to ligand field effects.  The method correlates molecular orbital orderings in 
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various geometries, and considers how the character of the HOMO affects the geometry of the 
MNO group.  The MNO group is bent when the HOMO is antibonding and linear when the 
HOMO is bonding.  In the Enemark-Feltham notation, {MNO}n, n represents the total number of 
metal d and NO π* electrons when NO is arbitrarily assigned as NO+.  The notation, which 
reflects the fact that there is significant mixing of metal d and π* NO orbitals, allows for some 
generalizations.5  For example, according to the Enemark-Feltham method, six-coordinate 
octahedral complexes with {MNO}6 are expected to be linear based upon molecular orbital 
correlation diagrams.  Exceptions occur and are understood by considering factors that influence 
the molecular orbital ordering, hence influence the MNO bond angle. The complexes described 
in this document are formally linear {RuNO+}6 complexes. 
1.3 CHARACTERIZATION OF RUTHENIUM NITROSYL COMPLEXES 
There are several characterization methods for ruthenium nitrosyl complexes in general and for 
determining the nature of the Ru-NO moiety.  Some of the more common methods are described 
in this section.27 
1H and 13C nuclear magnetic resonance spectroscopy are useful for determining the 
binding mode of the ligands.  Upon coordination to the Ru-NO moiety, 13C and  1H NMR signals 
of the ligands exhibit an upfield shift.  In general, the closer a proton or a carbon is to the 
electron withdrawing Ru-NO unit, the more downfield its signal.  However, exceptions attributed 
to magnetic anisotropy, induced either by the Ru-NO unit or by the ligand, do occur.  15N NMR 
spectroscopy is a direct indicator of the electronic nature of the nitrosyl nitrogen atom. With 15N 
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dimethylformamide as the reference, a bent 15NO− has a shift between 700 and 600 ppm.  A 
linear RuNO+  15N signal usually appears around 260 ppm. 
Infrared spectroscopy is also a powerful tool for characterizing ruthenium nitrosyl 
compounds.  In general, the NO− stretching mode absorbs around 1500 cm-1; the NO+ absorbs 
above 1800 cm−1.   The lower frequency observed for NO− is due to backbonding into the NO π* 
orbitals, which lowers the bond order and therefore the stretching frequency.  It is important to 
realize that the stretching frequency does not correlate with the Ru-NO angle.  There are both 
linear and bent Ru-NO+ and Ru-NO− complexes.  Thus, while infrared spectroscopy is useful for 
determining the electronic character of the NO moiety, it does not necessarily provide 
geometrical information.   
  The best way to determine the geometry of the RuNO moiety is by X-ray 
crystallography. An MNO group is considered to be linear if its MNO angle is between 165 and 
180° and bent if its angle is less than 165°. Crystal structures are also useful for observing 
changes in the ligand brought about by coordination to Ru.  
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2.0  BIS-PYRIDINE CARBOXAMIDE LIGANDS 
2.1 INTRODUCTION 
Ruthenium is the metal center of choice because it makes a relatively strong Ru-NO bond that 
can survive in physiological conditions and because ruthenium complexes are known to 
accumulate in tumors.36-42 NO lability can be tuned by alterations of the π-donor/π-acceptor 
character of the ligand set.  Strong π-donors push electron density onto NO.  Increased electron 
density then activates the Ru-NO moiety toward photolysis of NO•.   Coordination of π-donors 
in the position trans to NO have the strongest effect on NO, however, π-donors coordinated cis 
to NO have also been shown to decrease the nitrosyl stretching frequency35,49,50,52-55,65.  Chelated 
π-donors such as bis-phenolato and bis-carboxamido ligands, activate RuII(NO+) toward 
photolysis by pushing electron density toward NO.24,26,27  After photolysis the amido/phenolato 
donors then stabilize the RuIII-solvent complex formed by photolabilization.3,27,45-47 Finally, 
water solubility and biocompatibility make chelated amido donors useful as NO carriers through 
physiological environments.28-33  The RuNO complexes might then be used in photodynamic 
treatment of colon cancer or skin cancer.  Eventually side chains on the amido ligands or 
phenolato ligands can be selected to guide the complex toward specific targets.  
The first set of ligands prepared consists of bis-pyridyl bis-carboxamido ligands.  The 
carboxamido ligands will serve to activate the NO group toward photolysis, while the pyridyl 
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groups help maintain chelation under physiological conditions.  The coordinating pyridine 
carboxamide environment is constant while the backbone of the ligand is varied.  The first three 
ligands described have an aromatic backbone, which is either benzene, 2,3-diaminopyridine or 
3,4-diaminopyridine. The nitrogen in the aromatic is intended to enhance solubility.  The other 
two ligands have an ethane, propane backbone or a piperazine backbone.  Backbone variability 
introduces structural as well as electronic differences in the coordination environment.  Much of 
the report on N,N’-bis(2-pyridinecarboxamide)-1,2-benzene25, N,N′-bis(2-pyridinecarboxamide)-
1,2-ethane and -1,3-propane66 has been published. 
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2.2 N,N′-BIS(2-PYRIDINECARBOXAMIDE)-1,2-BENZENE 
2.2.1 Materials and Methods  
Note:  
A significant part of the material presented in this chapter is reproduced with permission from a 
publication in Inorganic Chemistry Communications, 7, Carol F. Fortney, Rex E. Shepherd, 
Synthesis and Characterization of a new {RuNO}6 complex, [Ru(NO)(bpb)Cl] (bpb = N,N′-bis(2-
pyridinecarboxamide)-1,2-benzne dianion), 1065-1070, copyright Elsevier, 2004.  
 
Trichloronitrosylruthenium dihydrate ([Ru(NO)Cl3(H2O)2])  (2.1) was prepared using a 
modification of the procedure of Fletcher.67 [RuCl3(H2O)3] (207.43 g/mol, 2.00g, 0.0096 mol, 1 
equiv) was dissolved in HCl (1 M, 15.0-18.0 ml,  > 1 equiv.) and heated to 100 °C in an oil bath.  
At 100 °C, an aqueous solution of NaNO2 (68.9 g/mol, 1.99 g, 3 equiv.) was added dropwise 
over one hour.  The dark red/black solution began to turn purple as NO2 was released.  After one 
hour the water was removed from the reaction mixture under vacuum (rotary evaporator, 90 °C).  
The remaining dark purple solid was dissolved in ethanol to separate the product from NaCl 
formed in the reaction.  NaCl was removed via vacuum filtration. Ethanol was removed under 
vacuum (rotary evaporator, 65-70 °C.) The extremely hygroscopic purple solid was stored in a 
desiccator with Drierite.   
 
N,N′-bis(2-pyridinecarboxamide)-1,2-benzene (bpbH2) (2.2) N,N′-bis(2-pyridine 
carboxamide)-1,2-benzene was prepared according to a literature procedure.68 1,2-
diaminobenzene (10.43 g, 0.0964 mol, 1 equiv) in pyridine (~ 50.0 ml) was added to a stirred 
solution of picolinic acid (23.73 g, 0.0193 mol, 2 equiv) in pyridine (~ 120 ml).   After triphenyl 
phosphite (50.7 ml, 0.1929 mol, 1 equiv) was added slowly, the reaction mixture was heated for 
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four hours in a water bath.  Brown crystals formed overnight at room temperature. Pale pink 
crystals were obtained by recrystallization from ethylacetate. 1H NMR (300 MHz, dimethyl 
sulfoxide-d6): δ 10.7 (s, 2H, NH2) 8.63 (dq, 2H, H-1); 8.15 (dt, 2H, H-4); 8.05 (td, 2H, H-3); 
7.75 (td, 2H, H-5), 7.64 (qd, 2H, H-2), 7.29 (td, 2H, H-6). 13C NMR (125 MHz, dimethyl 
sulfoxide-d6):  δ 162.74 (C=O), 149.42 (Pyridyl-ipso), 148.54 (C-1), 138.17 (C-3), 130.9 (Aryl-
ipso), 127.1 (C-2), 125.66 (C-6), 125.29 (C-5), 122.42 (C4); GC-MS m/z 318. 
 
Nitrosyl N,N′-bis(2-pyridinecarboxamido)-1,2-benzene chloride ruthenium(II)  (2.3) Was 
prepared using an procedure adapted from Vagg.69 [Ru(NO)Cl3(H2O)2] (0.861g, 0.0031 mol, 1 
equiv) was added to a stirred solution of  bpbH2 (0.999 g, 0.0031 mol, 1 equiv) in an ethanol/water 
solution (95 %,  ~60.0 ml, 65-70 °C).  After 12 hours, a fine brown solid (0.452 g, 0.00094 mol, 30 
%) was isolated by filtration, rinsed with ethanol, and dried in a 120 °C oven.  1H NMR (300 MHz, 
dimethyl sulfoxide-d6):  δ 9.25 (d, 2H, H-1), 8.54 (td, 2H, H-5), 8.21 (td, H-3), 8.2 1(dd, 2H, H-4), 
7.94 (dtd, 2H, H-2), 7.06 (td, 2H, H-6); 13C NMR (125 MHz, dimethyl sulfoxide-d6): δ 163.26 
(C=O), 158.11 (Pyridyl-ipso), 152.49 (C-1), 143.71 (Aryl-ipso), 141.8 (C-3), 128.05 (C-2), 126.40 
(C-4), 123.84 (C-6), 121.02 (C-5); IR (KBr): (νNO  = 1867cm-1); ESI-MS M + Na+ 505.9 (M+• = 
482). 
 
 
 11 
2.2.2 Results and Discussion     
The ligand, N,N′-bis(2-pyridinecarboxamide)-1,2-benzene (2.2) has been prepared68 previously and 
analyzed by X-ray crystallography.70  The {RuIINO+}6 compound [Ru(NO)Cl(bpb)] (2.3) was 
obtained from the reaction between [Ru(NO)Cl3 (H2O)2] and N,N′-bis(2pyridinecarboxamide--1,2-
benzene) in 95% ethanol/H2O at 75°C. Nuclear magnetic resonance spectroscopy (HH COSY, 
HMBC, and HMQC) allowed the unambiguous assignment of all  1H and 13C resonances. Figure 2.1 
displays the labeling system; 1H and 13C chemical shifts for 2.2 and 2.3 are compared in Table 2.1.  
The free ligand’s N-H resonance at δ 10.7 (s, 2 H) disappears upon exchange with D2O.  
Disappearance of the amido N-H resonance upon coordination indicates that the ligand is 
deprotonated. The only proton resonances that do not exhibit a downfield shift upon coordination are 
the benzene meta protons, H-6, which shift slightly upfield. As expected, the most significant down 
field shifts correspond to H-1 and H-5, the protons ortho to the pyridyl nitrogen and ortho to the 
nitrogen substituent on the diamido benzene moiety, respectively.    
The 13C resonances are more diagnostic because their proximity to the chelating nitrogen 
increases their sensitivity to the electron withdrawing character of the RuNO moiety. By 13C 
NMR the possibility that the amido functionality is bound to the metal center by the carbonyl 
oxygen can be eliminated because coordination there would generate a pronounced downfield 
shift of the 13C resonance for the carbonyl carbon.  The most noticeable downfield shifts 
correspond to the nitrogen bearing aryl-ipso carbon and the pyridyl-ipso carbon, which is bound 
to the coordinated pyridyl nitrogen.  H-6, C-5, and C-6 all exhibit upfield shifts upon 
coordination.                   
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Table  2.1- Chemical shiftsa for 2.2b and 2.3c 
a.  300 MHz; dmso-d6 
 b.  N,N′-bis(2-pyridinecarboxamide)-1,2-benzene (bpbH2) 
c.  [Ru(NO)(bpb)Cl] (bpb = N,N′-bis(2-pyridinecarboxamide)-1,2-benzene dianion) 
 *   Not applicable 
1H 1 2 3 4 5 6 7 
2.2 8.63 7.64 8.05 8.15 7.75 7.29 10.7 
2.3 9.25 7.94 8.39 8.21 8.54 7.06 * 
13C Ar-ipso Py-ipso C=O 
2.2 148.54 127.10 138.17 122.42 125.29 125.66 * 130.97 149.42 162.74 
2.3 152.49 128.05 141.88 126.40 121.02 123.84 * 143.71 158.11 163.26 
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Scheme 2.1 summarizes the mass spectrometry data obtained for 2.3.  Compound 2.3 exhibits 
minimal solubility in methanol, so ESI-MS only allowed detection of a small amount of the 
neutral compound  [Ru(NO)(bpb)Cl] plus Na+  at m/z = 506 2.3a.  Treatment of 2.3 with AgNO3 
produced the more soluble cation 2.3b.  Compound 2.3b, with a methanol molecule, situated 
trans to the nitrosyl group, exists in equilibrium in solution with its deprotonated neutral form 
2.3c.  Compound 2.3b is detected, with loss of methanol, at m/z = 448.  The neutral 2.3c is not 
detected by itself by ESI/MS.  However, 2.3d, (2.3c in the presence of K+) is detected at m/z = 
518.  This confirms the conclusion from the first ESI/MS experiment with 2.3 and provides 
further evidence that all four nitrogen atoms are coordinated to the metal center.   
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Scheme 1-ESI-MS data for [Ru(NO(bpb)Cl]  
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The infrared spectrum of 2.3 reveals that the nitrosyl group (νNO  = 1867cm-1) in 
[Ru(NO)(bpb)Cl] is activated, but to a lesser extent than in the ruthenium nitrosyl dioxocyclam 
complex (νNO =1845 cm-1).  The increased stretching frequency with respect to the dioxocyclam 
complex was anticipated because the amine donors of the dioxocyclam ligand have been 
replaced with π-accepting pyridyl donors in 2.3 therefore less electron density is available for 
back donation to the nitrosyl.  The NO stretching frequency and the fact that this is a six 
coordinate {RuNO}6 complex suggest that 2.3 is formally a linear RuIINO+ complex.    
At the time the report of 2.3 was submitted for publication the Mascharak published a 
report of its synthesis, as well as the synthesis of derivatives. Our data are in good agreement 
with theirs.  In addition a crystal structure of 2.3 confirmed that the RuNO moiety is linear and 
conclusions drawn from studies described in the introduction.  Photochemical studies showed 
that [Ru(NO)(bpb)Cl] exhibits photolytic loss of NO under mild UV radiation.26  
 
 
2.2.3 Conclusion 
In summary,   a six coordinate {RuNO}6 complex, [Ru(NO)(bpb)Cl] (2.3) was prepared and 
characterized by NMR spectroscopy, IR spectroscopy and ESI-MS. Compound 2.3 represents the 
first in a series of ruthenium nitrosyl bis-amido/bis-pyridyl and mixed amido/phenolato 
complexes being developed to elucidate the factors that regulate MNO character so that the 
RuNO group can be tuned for optimal photolytic activity.  
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2.3 N,N′-BIS(2-PYRIDINECARBOXAMIDE)-2,3-PYRIDINE 
2.3.1 Materials and Methods 
N,N′-bis(2-pyridinecarboxamide)-2,3-pyridine (2.4) was prepared according to a literature 
procedure.68  Triphenyl phosphite (d = 1.184 g/mL, 2.46 mL, 0.0094 mol) was added by pipette 
to a solution of picolinic acid (1.16 g, 0.0094 mol) and 2,3-diaminopyridine (0.513 g, 0.0047 
mol) in dry pyridine (5.0 mL). After four hours of stirring in an oil bath at 100 °C the reaction 
mixture was allowed to sit at room temperature for several days until crystals formed.  Clear 
crystals were collected by vacuum filtration.  Recrystallization from dichloromethane afforded x-
ray quality crystals.   1H NMR (600 MHz, DMSO-d6, δ):  10.91 (s, 1H, N-H (2)), 10.72 (s, 1H, 
N-H(1)), 8.74 (dd, 1H, H-17), 8.59 (dd, 1H, H-1), 8.42 (dd, 1H, H-10), 8.34 (dd, 1H, H-8), 
8.19(dd, 1H, H-14), 8.15 (d, 1H, H-4), 8.08 (td, 1H, H15), 8.04 (td, 1H, H-3), 7.70 (m, 1H, H-
16), 7.63 (m, 1H, H-2), 7.45 (dd, 1H, H-9);  13C{H} (125 MHz, DMSO-d6) δ):  163.58 (C-12, 
C=O), 162.51 (C-6, C=O), 148.91 (C-5, C-13), 148.77 (C-17), 148.62 (C-1), 144.71 (C-8), 
142.96 (C-11), 138.26 (C-3, C-15), 132.68 (C-10), 128.33 (C-7), 127.44 (C-16), 127.32 (C-2), 
122.64 (C-14), 122.36 (C-4), 122.32 (C-9); ESI-MS M+. = 319 
 
 
Reaction with [Ru(NO)Cl3(H2O)2]: The reaction was run according to a modified literature 
procedure.69 Trichloronitrosylruthenium (273.45 g/mol, 0.001 mol, 0.306 g) was added to an 
ethanol/water (95%, 40.0 mL) solution of N,N′-bis(2-pyridinecarboxamide)-2,3-pyridine (319.32 
g/mol, 0.358 g, 0.001 mol, 1 equiv) with stirring. The reaction mixture was stirred for ten hours 
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at 85.0 °C.  A brown precipitate was separated from the filtrate.  X-ray quality crystals were 
obtained after volume reduction under vacuum (rotary evaporator 55 °C) and slow evaporation 
of solvent at ambient temperature. The yield was low and not obtained.  The reaction will have to 
be scaled up to obtain NMR and IR data. 
2.3.2 Results and Discussion 
The ligand N,N′ -bis(2-pyridinecarboxamide)-2,3-pyridine was characterized by 1H NMR and 
13C NMR spectroscopy.  Chemical shift assignments were made based upon HH COSY, HMQC, 
and HMBC spectra. The labeling scheme for the NMR assignments is shown in Figure 2.2. 1H; 
13C NMR data are shown in Tables 2.2 and 2.3, respectively.  
There are some differences between 2.2, which has a benzene ring backbone, and 2.4. 
The addition of a nitrogen atom in 2.4 has a long range effect, which differentiates the pyridyl 
arms from each other for 2.4. The HH COSY spectrum (excluding N-H signals), shows the sets 
of pyridyl signals (Figure 2.3). For ligand 1.4, there is only one set of pyridyl signals. The 
resonance forms of the pyridine ring in 2.4 places positive charge on the carbon atoms ortho and 
para to the pyridine nitrogen.  For the 2,3-diaminopyridine ligand then, C-11 exhibits more of a 
positive character than does C-7 as shown by the 13C NMR data.  The signal for C-11 is at 
142.96 ppm while that for C-7 is at 128.33 ppm.  The corresponding carbon atoms in 1.4 show a 
single resonance at 130.97 ppm.  The remaining 1H and 13C signals within 2.4 differ only slightly 
from each other.  
 
 
 
 18 
  
 
N
N N
O O
N N
H H
12
3
4
8
9 10
14
15
1617
5 6
7 11
12
NH(1) NH(2)
13
2.4  
  
                                   Figure  2.2- N,N′-bis(2-pyridinecarboxamide)-2,3-pyridine  
 
Table  2.2-1H NMR Data for N,N′-bis(2-pyridinecarboxamide)-2,3-pyridine  
1H 1 2 3 4 8 9 10 14 15 16 17 N-H(1) N-H(2) 
 8.59 7.63 8.04 8.15 8.34 7.45 8.42 8.19 8.08 7.70 8.74 10.72 10.91 
 
Table  2.3-13C NMR Data for N,N′-bis(2-pyridinecarboxamide)-2,3-pyridine  
13C 1 2 3 4 5 6 7 8 9 10 
 148.62 127.32 138.26 122.36 148.91 162.51 128.33 144.71 122.32 132.68 
           
 11 12 13 14 15 16 17    
 142.96 163.58 148.91 122.64 138.26 127.44 148.77    
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Figure  2.3-HH COSY  of N,N′ -bis(2pyridinecarboxamide)-2,3-pyridine 
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Figure 2.4 shows the crystal structure of 2.4. Crystal intensity and collection data are reported in 
Table 2.4. Selected bond distances and angles are shown in Tables 2.5 and 2.6, respectively. The 
C(11)-C(7)-N(2) angle is 2° larger than that for C(7)-C(11)-N(4); there are no other remarkable 
differences between the pyridyl arms with respect to bond distances and bond lengths.  
 Table  2.4-Crystal data and refinements for 2.4 and 2.6 
 
 2.4 2.6 
Chemical Formula C17H13N5O2 C20H19Cl3N6O4.5RuS1.5
Formula Weight 319.32 670.92 
Temperature (K) 293(2)  150(2) 
Wavelength (Å) 0.71073 0.71073 
Crystal system Monoclinic Triclinic 
Space group P-2(1)/c P-1 
a (Å) 16.2399(9) 10.668(2) 
b (Å) 11.5058(6) 16.519(3) 
c (Å) 8.0877(4) 17.628(4) 
α (°) 90 63.144(4) 
β (°) 92.33(10) 84.309(5) 
γ (°) 90 79.441(5) 
Volume (Å3) 1509.96(1) 2724.1(10) 
Z 4 4 
Density (calculated) Mg/m3 1.405 1.636 
Absorption Coefficient (mm-1) 0.097 1.025 
F(000) 664 1344 
Crystal Size (mm3) 0.28 x 0.15 x 0.15 0.26 x 0.13 x 0.11 
θ range for data collection (°) 2.17 to 24.99 1.94 to 25.00 
Index Ranges -19 ≤ h ≤ 19 -12 ≤ h ≤ 12 
 -13 ≤ k ≤ 13 -19 ≤ k ≤ 19 
 -9 ≤ l ≤ 9 -20 ≤ l ≤ 20 
Reflections collected 11889 21758 
Independent reflections 2650 [R(int) = 0.0260] 9583 [R(int) = 0.1160] 
Completeness 99.9 % (θ =24.99°) 99.9 % (θ =25.00) 
Data / restraints / parameters 2650/ 0 / 269 9583 / 0 / 634 
Max. and min. transmissions 0.9856 and 0.9733 0.8956 and 0.7765 
Refinement Method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Goodness-of-fit on F2 1.343 1.101 
Final R indices[I > 2σ (I)] R1 = 0.0469, wR2 = 0.1205 R1 = 0.1006, wR2 = 0.2187 
R indices (all data) R1 = 0.0574, wR2 = 0.1247 R1 =0.1646, wR2 = 0.2432 
Largest diff. peak and hole (e  Å3) 0.155 and -0.144 3.606 and  -1.583 
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Figure  2.4-X-ray structure of 2.4 
Table  2.5-Selected bond distances for 2.4 
 
 
 
 
 
                      C(13)-C(14) 
O(2)-C(12) 1.215(2) O(1)-C(6) 1.221(2) C(10)-C(11) 1.386(3) 
N(4)-C(12) 1.349(2) N(2)-C(6) 1.347(2) C(9)-C(10) 1.372(3) 
N(4)-C(11) 1.405(2) N(2)-C(7) 1.413(2) C(8)-C(9) 1.372(3) 
N(4)-H(4N) 0.851(2) N(2)-H(2N) 0.858(2) N(3)-C(8) 1.332(3) 
C(12)-C(13) 1.502(2) C(5)-C(6) 1.494(3) N(3)-C(7) 1.333(2) 
N(5)-C(13) 1.333(2) N(1)-C(5) 1.338(2) C(7)-C(11) 1.393(2) 
N(5)-C(17) 1.331(2) N(1)-C(1) 1.331(2) C(4)-H(4) 0.89(2) 
C(16)-C(17) 1.371(3) C(1)-C(2) 1.371(3) C(14)-H(14) 095(2) 
C(15)-C(16) 1.361(3) C(2)-C(3) 1.355(3)   
C(14)-C(15) 1.376(3) C(3)-C(4) 1.376(3)   
1.374(2) C(4)-C(5) 1.375(2)   
 
Table  2.6-Selected bond angles for 2.4 
 C(3)-C(2)-C(1) 118.6(2) C(15)-C(16)-C(17) 118.42(2) 
C(2)-C(3)-C(4) 119.0(2) C(16)-C(15)-C(14) 118.9(2) 
C(3)-C(4)-C(5) 118.9(2) C(13)-C(14)-C(15) 118.86(1) 
C(4)-C(5)- N(1) 122.87(1) N(5)-C(13)-C(14) 123.08(1) 
C(5)- N(1)- C(1) 116.57(1) C(17)- N(5)-C(13) 116.57(1) 
C(13)-C(12)-O(2) 121.14(1) O(1)-C(6)-C(5) 121.80(1) 
N(4)-C(12)-C(13) 113.81(1) N(2)-C(5)-N(2) 115.01(1) 
C(12)- N(4)- C(11) 126.54(1) C(6)- N(2)- C(7) 125.29(1) 
C(10)-C(11)-N(4) 122.04(1) N(3)-C(7)-N(2) 114.14(1) 
C(7)-C(11)-N(4) 120.32(1) C(11)-C(7)-N(2) 122.52(1) 
C(11)-C(10)-C(9) 119.17(1) C(8)-N(3)- C(7) 117.40(1) 
C(10)-C(9)-C(8) 118.9(2) N(3)-C(8)-C(9) 123.4(2) 
O(2)-C(12)- N(4) 125.05(1) O(1)-C(6)- N(2) 123.17(1) 
C(10)-C(11)-C(7) 117.62(1) N(3)-C(7)-C(11) 123.32(1) 
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While the tetradentate complex 2.5 shown in Figure 2.5 has not been isolated from the 
reaction mixture at this time, at least two other products were obtained from the reaction between 
2.4 and [Ru(NO)Cl3(H2O].  The 1H NMR spectrum, shown in Figure 2.6, indicates that one 
product is coordinated by only one carboxamido nitrogen, as there is only one N-H resonance in 
the spectrum.  Assignment of 1H signals await 2D analysis.  Another product, for which the 
crystal structure was obtained, is shown in Figure 2.7.   
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Figure  2.5-Tetradentate  ruthenium nitrosyl complex 
 
 
Figure  2.6-1H NMR Spectrum of RuNO complex coordinated by one amido nitrogen 
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Figure  2.7-Product obtained from reaction mixture  
In 2.6 the ligand binds axially through the carbonyl oxygen, which is trans to NO, and 
through a pyridyl nitrogen atom, in an equatorial position, trans to a chloride.   The three chloride 
atoms are in the equatorial plane.  There are two slightly different forms of this crystal as shown 
in Figure  2.8.  Selected bond distances and angles are shown in Table 2.7.                                                             
                     
                       2.6                                                                          2.6′ 
Figure  2.8-Two forms of  trans-O bound complex 
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             Table  2.7- Selected bond distances (Å) and bond angles (°) for 2.6 and 2.6′ 
 
O(3)-N(6) 1.145(1) O(3′)-N(6′) 1.139(1) 
Ru-N(6) 1.733(9) Ru′-N(6′) 1.727(1) 
Ru-O(1) 2.054(7) Ru′-O(1′) 2.031(7) 
Ru-N(1) 2.067(8) Ru′-N(1′) 2.061(8) 
Ru-Cl(1) 2.350(3) Ru′-Cl(2′) 2.351(3) 
Ru-Cl(3) 2.361(3) Ru′-Cl(1′) 2.363(3) 
Ru-Cl(2) 2.369(3) Ru′-Cl(3′) 2.366(3) 
N(1)-C(1) 1.353(1) N(1′)-C(1′) 1.342(1) 
C(1)-C(2) 1.358(1) C(1′)-C(2′) 1.365(1) 
C(2)-C(3) 1.403(1) C(2′)-C(3′) 1.368(1) 
C(3)-C(4) 1.364(1) C(3′)-C(4′) 1.369(1) 
C(4)-C(5) 1.349(1) C(4′)-C(5′) 1.372(1) 
N(1)-C(5) 1.358(1) N(1′)-C(5′) 1.340(1) 
C(5)-C(6) 1.498(1) C(5′)-C(6′) 1.489(1) 
N(2)-C(6) 1.298(1) N(2′)-C(6′) 1.263(1) 
O(1)-C(6) 1.283(1) O(1′)-C(6′) 1.301(1) 
N(2)-C(7) 1.346(1) N(2′)-C(7′) 1.344(1) 
O(2)-C(12) 1.241(1) O(2′)-C(12′) 1.219(1) 
    
O(3)-N(6)-Ru 177.5(9) O(3′)-N(6′)-Ru′ 172.9(1) 
N(6)-Ru-O(1) 175.7(4) N(6′)-Ru′-O(1′) 174.6(4) 
N(6)-Ru-N(1) 96.9(4) N(6′)-Ru′-N(1′) 99.3(4) 
N(6)-Ru-Cl(3) 91.4(3) N(6′)-Ru′-Cl(1′) 88.93 
N(6)-Ru-Cl(1) 91.9(3) N(6′)-Ru′-Cl(2′) 91.1(3) 
N(6)-Ru-Cl(2) 95.3(3) N(6′)-Ru′-Cl(3′) 97.6(3) 
O(1)-Ru-N(1) 78.8(3) O(1′)-Ru′-N(1′) 78.2(3) 
O(1)-C(6)-C(5) 118.8(1) O(1′)-C(6′)-C(5′) 113.9(9) 
N(1)-C(5)-C(6) 111.1(1) N(1′)-C(5′)-C(6′) 115.0(9) 
Ru-N(1)-C(5) 115.8(7) Ru′-N(1′)-C(5′) 114.8(6) 
O(1)-C(6)-N(2) 126.7(1) O(1′)-C(6′)-N(2′) 128.4(1) 
N(5)-C(7)-N(2) 123.61 N(5′)-C(7′)-N(2′) 122.3(1) 
C(6)-O(1)-Ru 114.6(6) C(6′)-O(1′)-Ru′ 118.0(7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 The crystal structures for  2.6 and  2.6′ show that both are linear nitrosyl complexes with 
an N(6)-Ru-O(3) bond angle of 177.5(9) for 2.6 and 172.9(10) for 2.6′. That the N(6′)-Ru′-O(3′) 
angle deviates from linearity more than the N(6)-Ru-O(3) angle follows from the fact that the 
Ru′-O(1′) is shorter than the Ru-O(1) bond.  The oxygen atom, being trans to the strong π-
accepting NO group, transfers electron denstiy through RuII toward NO.  This transfer of electron 
density must be more efficient for 2.6′ than for 2.6 as evidenced by the shorter Ru′-O(1) and Ru′-
N(6) bonds as well as the bending of the Ru-NO moiety.   
For 2.6 and 2.6′ the Ru-Cl bond trans to N(1) of the pyridyl group is shorter than both of 
the other two Ru-Cl bonds.  This difference in bond length is due to the π-accepting ability of the 
pyridyl group.  The Ru-N(1) bond distances are about the same for 2.6 and 2.6′ However, the 
O(1)-C(5)-C(6) angle is 5° greater than that for O(1′)-C(5′)-C(6′) and the N(1)-C(5)-C(6) angle is 
4° less than the N(1′)-C(5′)-C(6′) angle.  The C(5)-N(1) distance for 2.6 is slightly larger than 
that for 2.6′.  The differences in bond distances and angles are interesting considering that the 
ligand is bound in the same fashion for both complexes.   
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2.3.3 Conclusion 
The ligand N,N′ -bis(2pyridinecarboxamide)-2,3-pyridine was characterized by 1H NMR and 13C 
NMR spectroscopy.  Chemical shift assignments were made based upon HH COSY, HMQC, and 
HMBC spectra. For N,N′ -bis(2-pyridinecarboxamide)1,2-benzene, 2.2, which has a benzene ring 
backbone, the pyridyl arms are identical.  For 2.4 the addition of a nitrogen atom in the aromatic 
backbone of the ligand has a long range effect which differentiates the pyridyl arms from each 
other.  The differences between 2.2 and 2.4 translate into differences in coordination mode. A 
resonance form of the 2,3-dicarboxamido pyridine moiety places positive character on C-11 of 
the ligand. That positive character seems to compete for the lone pair of the attached nitrogen 
atom. This may explain the unusual coordination mode depicted by the crystal structures.  A 
second product which appears to be bound through one carboxamido nitrogen was isolated and 
requires further characterization.   
A serendipitous outcome of these unexpected results is that this new ligand has the 
potential to become a binuclear ruthenium nitrosyl carrier,  similar to the binuclear complexes 
described in the appendix that Professor Shepherd prepared earlier in his career. Since the ligand 
is capable of coordinating through the carbonyl oxygen and one pyridyl group in one case and 
through at least one carboxamido nitrogen in the other, the rest of the ligand also might be able 
to bind to a second ruthenium center.  The pendant half of the ligand could also serve as an 
anchoring site for a cell or protein.   
During the ligand synthesis, a large amount of a second product was obtained.  NMR and 
mass spectral data indicate that the extra product is the monosubstituted 1,2-diaminopyridine. It 
has not been determined whether the substitution has occurred at N(4) or (2). An interesting 
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extension of this project would be to test the coordination preference of the monosubstituted 
ligand. 
The most intriguing characteristic of these new complexes is that the chloride ions are all 
in the equatorial plane.  For all other complexes isolated in this series, two chloride ions are 
displaced and one remains trans to NO.  It is not very likely that there was any 
[Ru(NO)Cl3(H2O)2] with H2O trans to NO, being that NO prefers to have stonger π-donors trans 
to it. Perhaps, upon coordination, the complex isomerizes to place NO trans to the oxygen.  That 
might explain the observation of two complexes with the same ligand coordination but with 
different conformations. The different conformations of the pendant ligand might be explained 
by crystal packing.  Infrared analysis using KBr pellets should give two NO peaks for a sample 
with these structures. In solution, if the differences are attributed to packing, the complexes 
should become equivalent. Therefore, NMR spectroscopy should also be diagnostic once more 
sample is prepared. 
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2.4 N,N′-BIS(2-PYRIDINECARBOXAMIDE)-3,4-PYRIDINE 
2.4.1 Materials and Methods 
N,N′-bis(2-pyridinecarboxamide)-3,4-pyridine (2.7) was prepared according to a literature 
procedure.68  Triphenyl phosphite (d = 1.184 g/mL, 2.43 mL,.0093 mol) was added slowly to a 
stirred solution of picolinic acid (1.15 g, 0.0093 mol, 2 equiv) and 3,4-diaminopyridine (109.13 
g/mol, 0.508 g, 0.0047 mol) in dry pyridine (5.0 mL). The reaction mixture was stirred for four 
hours in an oil bath at 100 °C.  Crystals formed in the reaction after several days at ambient 
temperature. Clear crystals were collected by vacuum filtration. X-ray quality crystals were 
obtained by recrystallization from chloroform.   1H NMR (500 MHz, DMSO-d6, δ): 10.97 (s, 1H, 
N-H (1)), 10.79 (s, 1H, N-H(2)), 8.77 (d, 1H, H-1), 8.67 (s, 1H, H-10), 8.57 (d, 1H, H-17), 8.47 
(d, 1H, H-9), 8.19 (m, 1H, H-4), 8.17 (m, 1H, H-14), 8.14 (d, 1H, H-8), 8.08 (m, 2H, H-15, H-3), 
7.71 (m, 1H, H-2), 7.66 (m, 1H, H-16) ; 13C{H} (125 MHz, DMSO-d6) δ):  163.89 (C-6, (C=O)), 
162.55 (C-12, (C=O)), 149.07 (C-5), 148.71 (C-1), 148.64 (C-17), 148.53 (C-13), 148.42 (C-10), 
147.49 (C-9), 125.03 (C-11), 138.46 (C-15), 138.20 (C-3), 127.64 (C-16), 127.35 (C-2), 139.48 
(C-7), 122.71 (C-14), 122.60 (C-4), 116.32 (C-8); ESI-MS M+. = 319 
 
Reaction with [Ru(NO)Cl3(H2O)2]: The reaction was run according to a modified literature 
procedure.69 An ethanol/water (95%, 3.0 mL) solution of trichloronitrosylruthenium (0.025 g, 
0.092 mmol,) was transferred by pipette to an ethanol/water (95%, 15.0 mL, 80.0 °C) solution of 
N,N′-bis(2-pyridinecarboxamide)-3,4-pyridine (0.0295 g, 0.092 mmol). The reaction mixture 
was stirred for ten hours at 80.0 °C.  A brown precipitate was removed from the reaction 
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mixture.  The filtrate volume was reduced under vacuum (rotary evaporator 55 °C) and stored at 
ambient temperature for crystal formation.   
2.4.2 Results and Discussion 
The ligand 2.7 was isolated in undetermined, but low yield and characterized by NMR 
spectroscopy.  The relatively low yield is attributed to formation of a monosubstituted side 
product based upon NMR spectroscopy.  The labeling scheme for NMR data is shown in Figure 
2.9; 13C and 1H NMR data are in Tables 2.8 and 2.9. Chemical shift assignments were made 
based upon HH COSY, HMBC, and HMQC spectra. The chemical shift assignments are similar 
to those of 2.4.  The pyridyl arms are differentiated by their position with respect to the nitrogen 
atom in 2,3-diaminopyridine backbone. The NMR signals for the pyridyl arm attached to C-7 
resonate slightly downfied from those attached to C-11 because of the positive character placed 
on C-7 by the resonance forms of 2,3-diaminopyridine.  This effect is illustrated by the 13C 
chemical shift differences between C-7 (139.48 ppm) and C-11 (125.03 ppm). This difference 
(14.45 ppm) is almost exactly the same as the difference in chemical shift observed for C-7 and 
C-11 in 1.6 (14.63 ppm). While the chemical shift difference is essentially the same, the 
chemical shift values for C-7 and C-11, at 125.03 ppm and 139.48 ppm are about 3 ppm upfield 
from the chemical shifts of C-7 and C-11 of 1.6, at 128.33 and 142.96 ppm, respectively.  This 
illustrates that the resonance effect is stronger at the ortho position than at the para position. 
Crystals, fine needles, obtained after recrystallization were too thin for X–ray analysis.   
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Figure  2.9-N,N′-bis(2-pyridinecarboxamide)-3,4-diaminopyridine  
 
Table  2.8-1H Resonances for N,N′-bis(2-pyridinecarboxamide)-3,4-pyridine 
1H 1 2 3 4 8 9 10 14 15 16 17 N-H(1) N-H(2) 
 8.77 7.71 8.08 8.19 8.14 8.47 8.67 8.17 8.08 7.66 8.57 10.97 10.79 
 
Table  2.9-13C Resonances for N,N′-bis(2-pyridinecarboxamide)-3,4-pyridine 
13C 1 2 3 4 5 6 7 8 9 10 
 148.71 127.35 138.20 122.60 149.07 163.89 139.48 116.32 147.49 148.42 
           
 11 12 13 14 15 16 17    
 125.03 162.55 148.53 122.71 138.46 127.64 148.64    
 
 
While the reaction with [Ru(NO)Cl3(H2O)2] was run, purification and complete NMR analysis 
are pending.  Precipitate formation and color change, indicate that a reaction occurred.  It is 
anticipated that this ligand will provide additional coordination modes different from the target 
complex, seen in Figure 2.10. The products are expected to be similar to those seen for 2.5.  
However, if the same trend is followed, coordination is expected to occur through the O(1) and 
N(1) of 2.7, rather than through O(2) and N(4) as seen in 2.5.  
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Figure  2.10-Tetradentate complex 
2.4.3 Conclusion 
The ligand N,N′-bis(2-pyridinecarboxamide)-3,4-diaminopyridine was synthesized and 
characterized by NMR spectroscopy and mass spectrometry. The relatively low yield is 
attributed to the formation of a monosubstituted side product. The NMR data are very similar to 
those obtained for 2.5.  The only observed difference being the placement of positive character 
on C-7 rather than C-11 for 2.7.  While products have not been isolated from the reaction 
between 2.7 and [Ru(NO)Cl3(H2O)2] they might be similar, but in opposite sense, to those 
obtained from the reaction between 2.5 and [Ru(NO)Cl3(H2O)2].   
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2.5 N,N′-BIS(2-PYRIDINECARBOXAMIDE)-1,2-ETHANE, -1,3-PROPANE  
2.5.1 Materials and Methods  
A significant part of the material presented in this chapter is reproduced with permission from a 
publication in Inorganic Chemistry Communications, 7, Carol F. Fortney, Steven J. Geib, Fu-
tyan Lin, Rex E. Shepherd, Synthesis and Characterization of [Ru(NO)(bpp)Cl⋅2H2O](bpp = 
N,N′-bis(2-pyridinecarboxamide)-1,3-propane dianion) and [Ru(NO)(bpe)Cl⋅2H2O] (bpe = 
N,N′-bis(2-pyridinecarboxamide)-1,2-ethane dianion), 1065-1070, copyright Elsevier, 2005.  
 
Materials and Measurements 
[RuCl3•xH2O], NaNO2, picolinic acid, 1,2-diaminopropane, 1,2-diaminoethane, pyridine, 
triphenylphosphite, chloroform and ethanol were obtained from Aldrich and used without further 
purification.   
 
Instrumentation  
1H, 13C{1H}  NMR, HMQC, HH COSY, and HMBC spectra were obtained on a Bruker 
AVANCE DRX 500  digital NMR spectrometer.  Infrared spectra of KBr or KCl pellets were 
obtained on Perkin Elmer BX FT-IR spectrophotometer.    Mass spectrometry was carried out on 
a Waters Q-TOF API US instrument using electrospray ionization or on a 571A HP GC-MS 
instrument.   
 
Syntheses 
Trichloronitrosylruthenium [Ru(NO)(Cl3)(H2O)] was prepared using a modification of 
the procedure of Fletcher et al.67 [RuCl3•xH2O] (207.43 g/mol, 2.00 g, 0.0096 mol, 1 equiv) was 
dissolved in 1 M HCl (15.0-18.0 ml,  > 1 equiv). The resulting solution was heated to 100° C in 
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an oil bath.  At 100° C, an aqueous solution of NaNO2 (68.9 g/mol, 1.99 g, 3 equiv.) was added 
dropwise over one hour.  The dark red solution began to turn purple as NO2 was released.  After 
one hour, the water was removed from the reaction mixture under vacuum (rotary evaporator, 90 
°C).  The remaining dark purple solid was dissolved in ethanol to separate [Ru(NO)(Cl3)(H2O)] 
from NaCl formed in the reaction.  NaCl was removed via vacuum filtration. Ethanol was 
removed under vacuum (rotary evaporator, 65-70° C.) The extremely hygroscopic purple solid 
was stored in a desiccator with Drierite.   
 
N,N′-bis(2-pyridine carboxamide)-1,2-ethane (bpeH2) (2.9) was prepared according to 
a modified literature procedure.68 1,2-diaminoethane (60.10 g/mol, d = 0.899 g/ml, 3.66 g, 0.060 
mol, 1 equiv) in pyridine (~ 12.0 ml) was added to a stirred solution of picolinic acid (123.11 
g/mol, 14.76 g, 0.119 mol, 2 equiv) in pyridine (~ 48.0 ml).   After Triphenyl phosphite (310.29 
g/mol, d = 1.184 g/ml. 31.5 ml, 0.119 mol, 2 equiv) was added slowly, the reaction mixture was 
heated for four hours in an oil bath (100° C).  Pale yellow crystals formed overnight at room 
temperature. White crystals were obtained by recrystallization from chloroform. Yield : 14.06 g, 
0.0520 mol, 87 % yield;  1H NMR (500 MHz, DMSO-d6): δ 8.95 (s, 2H, NH2) 8.62 (d, 2H, H-1); 
8.01 (d, 2H, H-4); 7.97 (td, 2H, H-3); 7.57 (td, 2H, H-5), 3.52 (m, 2H, H-5 & 6); (1H NMR 500 
MHz, CDCl3) δ 8.52 (d, 2H, H-1), 8.37 (s, 2H, NH2), 8.16 (d, 2H, H-4), 7.80 (td, 2H, H-3), 7.38 
(td, 2H, H-2), 3.73 (m, 2H, H-5 & 6). 13C {1H} NMR (125 MHz, DMSO-d6):  δ 164.16 (C=O), 
149.92 (Pyridyl-ipso), 148.31 (C-1), 137.66 (C-3), 126.39 (C-2), 121.81 (C-4), 38.84 (C-5 & 6); 
13C {1H}  NMR (125 MHz, CDCl3 chloroform): δ 164.96 (C=O), 149.77 (Pyridyl-ipso), 148.10 
(C-1), 137.25 (C-3), 126.14 (C-2), 122.21 (C-4),  39.51 (C-5 & 6).            
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 Chloro-nitrosyl-N,N′-bis(2-pyridinecarboxamido)-1,3-ethane-ruthenium(II). 
[Ru(NO)(bpe)Cl•(H2O)2] (2.10) was prepared using an adapted procedure from Vagg.69 
[Ru(NO)Cl3(H2O)] (0.500g, 0.002 mol, 1 equiv) was added to a stirred solution of 2.9 (0.494 g, 
0.0018 mol, 1 equiv) in an ethanol/water solution (95 %, ~60.0 ml, ~ 85° C).  After 12 hours at 
reflux, a fine brown solid was obtained and removed by filtration. Upon reduction of the filtrate 
volume under vacuum (rotary evaporator, 30° C) an orange solid precipitated..  The solid was 
rinsed with small amounts of ethanol and dried at ~100° C.  X-ray quality crystals were obtained 
from a concentrated solution of [Ru(NO)(bpe)Cl•(H2O)2] in ethanol. Yield 0.247g, 30 % yield;  
1H NMR (500 MHz, DMSO-d6):  δ 9.23 (d, 2H, H-1), 8.34 (td, 2H, H-3), 8.08 (d, H-4), 7.90 (dd, 
2H, H-2), 4.02 (m, 2H, H-5′ & 6), 3.91 (m, 2H, H-5 & 6′); 13C {1H} NMR (125 MHz, DMSO-
d6): δ 166.56 (C=O), 157.76 (Pyridyl-ipso), 152.40 (C-1), 141.44 (C-3) 127.70 (C-2),  125.53 (C-
4), 51.62 (C-5 & 6); IR (KBr): νNO  = 1825cm-1; ESI-MS M + Na+ 457.95 (M+• = 434.77). 
 
N,N′-bis(2-pyridine carboxamide)-1,2-propane (bppH2) (2.11) was prepared according 
to a literature procedure.68 1,2-diaminopropane (74.13 g/mol, d = 0.888 g/ml, 4.71 ml, 3.71 g, 
0.050 mol, 1 equiv) in pyridine (~ 20.0 ml) was added to a stirring solution of picolinic acid 
(123.11 g/mol, 12.3 g, 0.099 mol, 2 equiv) in pyridine (~ 40 ml).   After triphenyl phosphite 
(310.29 g/mol, d = 1.18 g/ml, 26.27 ml, 31.0 g, , 0.099 mol, 2 equiv) was added slowly, the 
reaction mixture was heated for 4 h in an oil bath ~ 100° C.  A brown oil was obtained after 
solvent evaporation (rotary evaporator, ~80 °C). The oil was dissolved in chloroform (~ 50 ml), 
washed with water (~ 50 ml, 3 times), saturated sodium bicarbonate solution ( ~50 ml, 4 times), 
and finally with water (~ 50 ml, 3 times).   
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The chloroform solution was dried over magnesium sulfate and concentrated under 
vacuum (rotary evaporator, ambient temperature).  A powdery white precipitate formed as the 
concentrated solution was added dropwise over one hour to diethyl ether (~ 70 ml, 0° C) with 
stirring.  Recrystallization of the white precipitate from chloroform yielded white crystals. Yield: 
6.75 g, 47 % yield) 1H NMR (500 MHz, DMSO-d6): δ 8.99 (t, 2H, NH2) 8.61 (d, 2H, H-1), 8.03 
(d, 2H, H-4), 7.95 (t, 2H, H-3); 7.57 (td, 2H, H-2), 3.34 (q, 4H, H-5), 1.75 (qn, 2H, H-6). 
13C{1H}  NMR (125 MHz, DMSO-d6):  δ 163.91 (C=O), 150.05 (Pyridyl-ipso), 148.31 (C-1), 
137.68 (C-3), 126.35 (C-2), 121.79 (C-4), 36.29 (C-5), 29.42 (C-6); GC-MS m/z 284. 
 
Chloronitrosyl-N,N′-bis(2-pyridinecarboxamido)-1,3-propane-ruthenium(II), 
[Ru(NO)(bpp)Cl•(H2O)2] (2.12) (448.86 g/mol, 0.080 g, 1.78 x 10-4 mol, 10 % yield), was 
prepared by the same procedure as described above for 2.9. Recrystallization from an from 
DMSO provided X-ray quality crystals. 1H NMR (500 MHz, DMSO-d6):  δ 9.24 (d, 2H, H-1), 
8.38 (t, 2H, H-3), 8.18 (d, H-4), 7.91(t, 2H, H-2), 3.78 (m, 2H, H-5), 3.54 (t, 2H, H-5′), 2.10 (m, 
2H, H-6′), 1.77 (q, 2H, H-6); 13C{1H} NMR (125 MHz, DMSO-d6): δ 168.83 (C=O), 154.23 
(Pyridyl-ipso), 150.21 (C-1),  141.67 (C-3), 127.31 (C-2), 125.20  (C-4), 46.23 (C-5), 30.19 (C-
6); IR (KBr): (νNO  = 1838 cm-1); ESI-MS M + Na+ 471.97.  
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2.5.2 Results and Discussion 
Crystallographic Data Collection 
X-ray quality crystals were obtained for 2.10 and 2.12 by slow evaporation of ethanol from the 
reaction mixture filtrate. Crystals of 2.12 were also obtained from DMSO after the reaction 
mixture filtrate was reduced in volume and taken up in DMSO. The crystal structure shown for 
2.9 is from a crystal obtained in DMSO. Data collections were performed at room temperature 
on a Bruker Smart Apex CCD diffractometer using graphite-monchromated Mo Kα (λ = 0.71073 
Å) radiation.  Full crystallographic details are deposited in the Cambridge Structural Database 
(CCD 245015 and CDC245016).  Crystal and intensity collection data are reported in Table 2.10. 
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Table  2.10-Crystal data and refinements for 2.10 and  2.12 
 2.10 2.12 
Chemical Formula C15H18ClN5O5Ru C14H16ClN5O5Ru 
Formula Weight 484.86 470.84 
Temperature (K) 293(2)  295(2) 
Wavelength (Å) 0.71073 0.71073 
Crystal system Triclinic Triclinic 
Space group P-1 P-1 
a (Å) 7.6860(1) 7.3057(7) 
b (Å) 11.180(2) 11.0170(1) 
c (Å) 11.462(2) 11.7851(1) 
α (°) 80.47(3) 79.900(2) 
β (°) 74.99(3) 74.622(2) 
γ (°) 72.58(3) 74.29(2) 
Volume (Å3) 903.6(3) 874.93(1) 
Z 2 2 
Density (calculated) Mg/m3 1.767 1.787 
Absorption Coefficient (mm-1) 1.054 1.086 
F(000) 480 472 
Crystal Size (mm3) 0.37 x 0.34 x 0.21 0.38 x 0.18 x 0.13 
θ range for data collection (°) 1.85 to 32.59 1.80 to 32.54 
Index Ranges -11 ≤ h ≤ 11 -10 ≤ h ≤ 10 
 -16 ≤ k ≤ 16 -16 ≤ k ≤ 16 
 -17 ≤ l ≤ 17 -17 ≤ l ≤ 17 
Reflections collected 11590 11486 
Independent reflections 6118 [R(int) = 0.0395] 5976 [R(int) = 0.0348] 
Completeness 92.7 % (θ =32.59°) 94.2 % (θ =32.54°) 
Data / restraints / parameters 6118 / 0 / 244 5976 / 0 / 235 
Max. and min. transmissions 0.8091 and 0.6965 0.8717 and 0.6831 
Refinement Method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Goodness-of-fit on F2 1.167 1.092 
Final R indices[I > 2σ (I)] R1 = 0.0790, wR2 = 0.2595 R1 = 0.0615, wR2 = 0.1487 
R indices (all data) R1 = 0.0886, wR2 = 0.2656 R1 = 0.0870, wR2 = 0.1606 
Largest diff. peak and hole (e  Å3) 4.009 and -1.477 1.682 and  -.0598 
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Crystal Structure Data 
Figures 2.11  and 2.12 display the molecular structures of 2.10 and 2.12, respectively.  Tables 
2.11 and 2.12 show selected bond lengths and angles for 2.10 and 2.12, respectively.  Both the 
pyridyl and deprotonated amido nitrogen atoms of the tetradentate bpe2−  and bpp2− ligands 
coordinate to the ruthenium center in the equatorial plane to form a slightly distorted octahedral 
compound with axial chloride and nitrosyl substituents.  The Ru-N amido and Ru-N pyridyl. The 
Ru-N-O angle in both compounds is linear, 177.0(4) for 2.10 and 177.5(6) for 2.12.  It follows 
that the N-O bond length for 2.10 (2.120(5) Å) is very similar to that for 2.12 (2.123(8) Å). That 
the Ru-NO (1.732(6) Å)  and  Ru-Cl (2.368(3)Å)  bond lengths for 2.12 are slightly shorter than  
those in 2.10 (Ru-NO (1.742(4)) Å and Ru-Cl (2.383(1)) Å) may indicate that the NO group 
exerts a slightly stronger trans strengthening effect in 2.10 than in 2.12.  The longer Ru-Cl and 
Ru-N(5) bonds in 2.10 may also be due to the smaller bite angles of the bpe2- ligand as discussed 
below.  
 For both complexes the  ruthenium center is displaced toward the nitrosyl group from the 
plane defined by the nitrogen atoms (0.145 Å in 2.12 and 0.167 Å in 2.10) due to the different 
bite angles of the ligands.  More displacement is required to alleviate the steric interaction with 
the rings in 2.10 because the five member chelate ring has a smaller bite angle (84.2(1)°).26,50  
The smaller N(2)-Ru-N(3) angle in 2.10 also allows a larger N(1)-Ru-N(4) angle of 115.04(14) 
Å). The  six member chelate ring in 2.12, which has a bite angle of 95.4(3)°,  forces a smaller 
N(1)-Ru-N(4) angle of 107.3(2)°. The smaller N(1)-Ru-N(4)  in 2.12 causes the pyridyl groups 
to tip out of the plane slightly more in 2.12 than in 2.10 to minimize steric interaction between 
H-1 and H-14. Tilting of chelated pyridyl groups has been observed by others.26 Both pyridyl 
rings involving N(1) on 2.10 and 2.12 exhibit less of a tilt than do those involving N(4).   
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The carbon-carbon bonds in the 5 member ring formed by the diamide in 2.10 exhibit 
typical bond lengths and angles. The N(5)-Ru-N(2) angle is 98.48(17) ° while the N(5)-Ru-N(3) 
angle is a little less at 96.35(16)°. The six member ring formed upon chelation of the bpp2− 
ligand exhibits angles that are little larger than those of a six member ring. The largest deviation 
from the typical value of 112°  is the C(8)-C(9)-N(3)  angle which is 115.87°.   In 2.12 the N(5)-
Ru-N(2) and N(5)-Ru-N(3) angles, at 95.9(3)° and 93.7(3)°, repectively, deviate less from 90° 
than do those in 2.10. 
Finally, as Figure 2.13 shows, there are short close contacts between the chloride ion and 
the hydrogen atom on the pyridyl ring that is para to the nitrogen of the heterocyle.  This 
interaction is great enough to pull the hydrogen atoms attached to C-10 in 2.10 and C-12 in 2.12 
slightly out of the plane of the rest of the hydrogen atoms. 
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 2.10 
Figure  2.11-Molecular structure of [Ru(NO)(bpe)Cl]  
 
 
Table  2.11- Selected bond distances (Å) and bond angles (°) for 2.10 
O(3)-N(5) 1.140(5) O(2)-C(9) 1.238(5) 
Ru-N(5) 1.742(4) O(1)-C(6) 1.231(5) 
Ru-Cl 2.383(1) N(2)-C(7) 1.471(6) 
Ru-N(1) 2.118(3) C(7)-C(8) 1.532(8) 
Ru-N(4) 2.127(4) N(3)-C(8) 1.456(6) 
Ru-N(3) 1.980(3) N(3)-C(9) 1.315(6) 
Ru-N(2) 1.983(4) N(2)-C(6) 1.329(6) 
    
O(3)-N(5)-Ru 177.0(4) N(3)-Ru-N(4) 79.51(1) 
N(5)-Ru-Cl 174.2(1) N(3)-Ru-N(1) 162.6(1) 
N(5)-Ru-N(1) 92.53(1) N(2)-Ru-N(4) 161.1(1) 
N(5)-Ru-N(4) 92.81(1) C(8)-N(3)-Ru 112.5(3) 
N(5)-Ru-N(3) 96.39(1) N(3)-C(8)-C(7) 110.4(4) 
N(5)-Ru-N(2) 98.48(1) C(7)-N(2)-Ru 113.4(3) 
N(3)-Ru-N(2) 84.20(1) N(2)-C(7)-C(8) 109.3(4) 
N(1)-Ru-N(4) 115.0(1) N(3)-C(9)-C(10) 112.2(4) 
N(2)-Ru-N(1) 79.70(1) N(2)-C(6)-C(5) 112.7(4) 
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               2.12 
 
Figure  2.12-X-ray structure of  [Ru(NO)(bpp)Cl] 
 
 
 
 
 
Table  2.12- Selected bond distances (Å) and angles (°) for  2.12 
 
 
O(3)-N(5) 1.143(8) O(1)-C(6) 1.246(8) 
Ru-N(5) 1.732(6) O(2)-C(10) 1.252(9) 
Ru-Cl 2.368(2) N(2)-C(6) 1.321(9) 
Ru-N(1) 2.129(5) N(3)-C(10) 1.298(1) 
Ru-N(4) 2.147(7) N(2)-C(7) 1.460(9) 
Ru-N(3) 2.039(6) C(7)-C(8) 1.517(1) 
Ru-N(2) 2.034(6) C(8)-C(9) 1.522(1) 
  N(3)-C(9) 1.468(1) 
    
O(3)-N(5)-Ru 177.5(7) N(3)-Ru-N(4) 77.9(3) 
N(5)-Ru-Cl 176.4(2) N(3)-Ru-N(1) 171.1(2) 
N(5)-Ru- N(1) 93.2(3) N(2)-Ru-N(4) 169.0(2) 
N(5)-Ru- N(4) 93.3(3) N(2)-C(7)-C(8) 112.6(6) 
N(5)-Ru- N(3) 93.7(3) C(7)-C(8)-C(9) 115.8(7) 
N(5)-Ru- N(2) 95.9(3) C(9)-N(3)-Ru 123.4(5) 
N(2)-Ru- N(3) 95.4(3) C(7)-N(2)-Ru 123.5(5) 
N(1)-Ru- N(4) 107.3(2) N(3)-C(10)-C(11) 114.1(6) 
N(2)-Ru- N(1) 78.3(2) N(2)-C(6)-C(5) 113.5(6) 
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 2.10 
 
      2.12 
                                       Figure  2.13-Close contacts in the crystal lattices of 2.10 and 2.12 
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Infrared Data 
The infrared spectrum of a pure sample of 2.10 in KBr showed a split nitrosyl peak with one 
peak at 1852 cm−1 and the other at 1825 cm−1. Split NO peaks have been observed for complexes 
having only one NO group. For example, splitting of the absorbance associated with the NO 
stretching mode has been observed for cis-[RuCl(en)2(NO)]Cl2, [RuBr(en)2(NO)]Br2, 
[RuI(en)2(NO)]I2,55 [Ru(NH3)5(NO)]Cl3•H2O,71and mer-[RuX3(en)(NO)] where X = Cl, Br, and 
I.72 For the complex ions the splitting has been attributed to an interaction between the 
counterion and the NO group.2,71  For neutral complexes, the splitting has been explained by a 
slight difference in the conformation of the ethylenediamine ligand induced in sample 
preparation.55  Unexpected peaks in infrared spectra, particulary with KBr pellets, have also been 
attributed to reactions with KBr and to interactions with KBr.73 To eliminate the possibility of 
interaction with KBr as the cause of the extra NO stretch, a spectrum was obtained using a KCl 
pellet.  In this case (Figure 2.14a) exhibited only one NO stretch at 1825 cm1 and a shoulder of 
another at 1850 cm-1. This result suggests that bromide might displace chloride when the sample 
is prepared in KBr.  Hence, only one NO peak is observed when the sample is prepared in KCl.  
However, the Ru-Cl bond is quite strong, especially when it is trans to NO.  Moreover, if Br− had 
displaced Cl− the peak that should remain when the spectrum is obtained in KCl should be the 
one with the highest stretching frequency.  Since the lower frequency peak remains, exchange 
with bromide was not the cause of the splitting.  Another spectrum of the same KCl pellet of 2.10 
obtained after several days of being exposed to air (Figure 2.14b) showed two NO peaks of equal 
intensity.  The extra peak along with an increase in the intensity of the peak representing the O-H 
stretching mode suggested that water might be the cause of the splitting.  A final IR spectrum 
(Figure 2.14c),  obtained after the same KCl pellet was stored for two days at 120° C to remove 
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the water, exhibited only one NO peak at 1825 cm−1 and lacked the O-H peak.  Therefore it was 
concluded that water is the cause of the split NO peak. Only one NO peak was observed in the 
infrared spectrum of 2.12  at 1868 cm−1.  Given their similar N-O bond lengths the stretching 
frequency for 2.12 seemed a little high compared to that for 2.10. To test whether the peak was 
actually two overlapping peaks, the KBr pellet of 2.12  was dried at 120 °C.  Figure 2.15  shows 
that after about three hours drying, the peak representing the NO stretching frequency had shifted 
to 1838 cm−1 as the water peak decreased in size. A peak at about 1384 cm-1 is characteristic of 
all RuNO compounds derived from [Ru(NO)Cl3(H2O)2] is observed in the spectra for both 
compounds and is assigned to the Ru-NO bending mode.22  
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     Figure  2.14- IR spectrum of  [Ru(NO)(bpe)(H2O)2] KCl pellet  
   a.  immediately after preparation; b.  after several days in air at ambient temperature  c. after two days in    
        120° C oven 
 
 
Figure  2.15- a. Fresh [Ru(NO)(bpp)Cl] KBr pellet; b. After 3 hours at 120° C 
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Figure  2.16-Numbering schemes for 2.9, 2.10, 2.11, and 2.12 
 
                        Table  2.13-1H and 13C Chemical Shiftsa for 2.9b,  2.10c, 2.11d, and 2.12e
 
 
 
 
 
 
 
 
 
 
 
 
 
 a.  500 MHz for 1H;  125 MHz for 13C; dmso-d6 
 b.  N,N′-bis(2-pyridinecarboxamide)-1,2-ethane (bpeH2) 
c.  [Ru(NO)(bpe)Cl] (bpp = N,N′-bis(2-pyridinecarboxamide)-1,2-ethane dianion) 
d.  N,N′-bis(2-pyridinecarboxamide)-1,2-propane (bppH2) 
f.  Prime indicates methylene proton oriented toward the Ru-NO moiety   
*   Not applicable  
1H 1 2 3 4 5 
 
5′ f 6 
 
6′ f 
 
7  
 
2.9 8.62 7.57 7.97 8.01 3.52 * 3.52 * 8.95   
2.10 9.23 7.90 8.34 8.08 3.91 4.02 4.02 3.91 *   
2.11 8.61 7.57 7.95 8.03 3.34 * 1.75 * 8.99   
2.12 9.24 7.91 8.38 8.18 3.78 3.54 1.77 2.10 *   
13C         
  
Py-ipso C=O 
2.9 148.31 126.39 137.66 121.81 38.48 * 38.48 * * 149.92 164.16 
2.10 152.40 127.70 141.44 125.53 51.62 * 51.62 * * 157.76 166.56 
2.11 148.31 126.35 137.68 121.79 36.29 * 29.42 * * 150.05 163.91 
2.12 150.21 127.31 141.67 125.20 46.23 * 30.19 * * 154.23 168.83 
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 Figure 2.16 shows the numbering schemes for 2.9, 2.10, 2.11 and 2.12. The 1H  and 13C NMR 
data, obtained in DMSO-d6, are shown in Table 2.13.  1H  and 13C assignments are based on the 
HH COSY and HMQC spectra.  The HH COSY and HMQC spectra for the pyridyl resonances 
of 2.9 are shown in Figures 2.17 and 2.18, respectively. Figure 2.17 depicts the correlations 
between H-2, H-3 and H-1, between H-3 and H-4, and between H-1 and H-2.  A correlation (not 
shown) also exists between the ethylene protons at 3.52 ppm and and the amide protons at 8.95 
ppm. 
 
N-H 1 4 3 2
N
-H
1
2
4
3
 
                          Figure  2.17- Pyridyl region of HH COSY spectrum of 2.11 
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The HMQC spectrum in Figure 2.18 shows the correlation of each proton resonance with 
its respective carbon resonance. Quaternary carbon signals at 149.77 ppm and 164.96 ppm in the 
HMQC spectrum are assigned to the pyridyl-ipso carbon and the carbonyl carbon, respectively, 
based upon the HMBC spectrum.74  The most downfield 13C signal that exhibits a proton 
correlation, appears at 148.10 ppm and corresponds to H-1.  H-1 is also the most downfield 
doublet by virtue of its proximity to the electron-withdrawing the pyridyl nitrogen. The next 
most downfield doublet, H-4, correlates with the second most upfield 13C resonance.  This might 
be rationalized by considering the magnetic anisotropy induced by the ring current as well as the 
different resonance forms of the pyridine ring.75,76    Except for the extra carbon and proton 
signals associated with the extra methylene carbon in 2.11, the NMR data for 2.11 is almost 
exactly the same as that for 2.9.  
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                                          Figure  2.18-Pyridyl region of HMQC spectrum of 2.11 
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Table 2.13 compares the 1H and 13C data for 2.9, 2.10, 2.11 and 2.12.  The lack of an N-H 
signal in the 1H NMR spectra for 2.10 and 2.12 indicates that each ligand coordinates in its 
deprotonated form.  Due to the electron withdrawing nature of the Ru-NO center,22 all proton and 
carbon resonances shift downfield upon coordination to ruthenium.  The ethylene carbon atoms are 
undifferentiated in the 13C spectrum of 2.10,  however the protons associated with them, H-5 and 
H-6, are differentiated by their proximity to the nitrosyl group.72,77  Figure 2.19 illustrates how the 
ethylene protons’ signal splits  into two downfield-shifted multiplets upon formation of 2.10. The 
most downfield multiplet at 4.02 ppm is assigned to H-5′, the  axial proton on carbon 5, and to H-
6, the equatorial proton on C-6. The signal at 3.90 ppm represents H-5 and H-6′, which are on the 
chloride face of the compound and farthest from the NO group.  It might be helpful to refer to the 
crystal structure of 2.10 in Figure 2.11; but be aware of the different numbering scheme. 
 
 
                              Figure  2.19- 1H NMR signal for ethylene protons of 2.9 and 2.10 
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In 2.9 the protons on C-5, which are bonded to the amido nitrogens, are identical;  
however, they are in different environments than those on the central methylene carbon, C-6.  Thus 
the spectrum exhibits a triplet at 3.34 ppm for protons labeled H-5  and a multiplet at 1.75 ppm for 
protons labeled H-6.  Coordination of 2.9 causes both methylene signals to shift downfield and 
split into two groups of two signals. One of the signals, a doublet of doublets, at 3.78 ppm, has 
been assigned to the protons that are directed toward the nitrosyl group; the other signal, an 
apparent triplet at 3.54 ppm has been assigned to those oriented toward the chloride.  The central 
methylene resonance is also split into two multiplets.  Again, the most downfield shifted signal at 
2.10 ppm has been assigned to the proton which is directed toward the nitrosyl group while the 
negligibly shifted resonance at 1.77 ppm is assigned to the proton directed away from the NO 
group.  
As previously mentioned, all 1H and 13C signals shift downfield upon coordination.  
However, there are some interesting differences in the magnitude of the shift for 2.10 and 2.12.  
For 2.10 both carbons which are bonded to the amido nitrogen atoms (C-5) resonate  13.14  ppm 
more downfield than those of the free ligand.  This compares to a downfield shift of 9.94 ppm for 
the analogous carbon atoms in 2.12.   Also, C-1 and the pyridyl ipso  signals are more affected 
upon coordination in 2.10 than they are in 2.12.  For 2.10 for C-1  shifts 4.09 ppm, while that for 
2.12 C-1 shifts only 1.9 ppm. A difference of similar magnitude is seen for the pyridyl ipso carbon 
which is downfield shifted 7.84 ppm in 2.10 and only 4.18 ppm for 2.12. The  carbonyl  signal, on 
the other hand, is less responsive to coordination in 2.10 than it is in 2.12. In 2.10 the carbonyl 
carbon 13C signal shifts downfield 2.40 ppm while in 2.12 it shifts 4.92 ppm.  
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 2.5.3 Conclusion 
The {RuNO}6 compounds, [Ru(NO)(bpe)Cl•2H2O)] and [Ru(NO)(bpp)Cl•2H2O], are distorted 
octahedral compounds with the chloride ligand trans to a linearly bound NO group. The 1H and 
13C spectra suggest that the compounds maintain the same coordination geometry in solution as 
they do in the solid state. The crystal structure reveals that all of the ruthenium-nitrogen bonds in 
the equatorial plane are shorter for 2.10 than for 2.12.  Accordingly 13C and 1H NMR analyses 
shows that carbons bonded to nitrogen and their respective protons are more downfield shifted in 
2.10 than in 2.12 upon coordination.  An exception is the 13C signal of the carbonyl carbon which 
is less downfield shifted in upon coordination of 2.10 than it is upon coordination of 2.12.  
The nitrosyl stretching frequencies of 1825 cm-1 for 2.10 1838 cm-1 for 2.12 are in good 
agreement with literature values for similar compounds.1,26,55,78  That the NO stretching 
frequencies of 2.10 and 2.12 are less than that for the [Ru(NO)(bpb)Cl] compound (1867 cm-1) 
indicates that more electron density is pushed on to the NO group by the bpe2− and bpp2− ligands 
than by the bpb2−  ligand. 
The infrared spectrum of 2.10 exhibited a distinctly split NO peak. Split NO peaks have 
been observed and attributed to interactions with counter ions, to slight variations in NO and  
ligand conformation, to the solvent when the sample is prepared in solution, and with reactions 
with KBr in KBr pellets.73,79 The split NO peak exhibited by 2.10 is attributed to hydrogen 
bonding interaction with water in the KBr pellet.  Drying the KBr pellet of 2.12 revealed that 
there was a split NO peak for 2.12 as well.  Drying of a KBr pellet of  [Ru(NO)(bpb)Cl]  
removed water but the NO peak remained unchanged.   This can indicate that the nitrosyl oxygen 
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atoms in 2.10 and in 2.12 exhibit a higher basicity, therefore an increased propensity to hydrogen 
bond,73 compared to that in [Ru(NO)(bpb)Cl] (1.5).   
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2.6 N,N′-BIS(2-PYRIDINECARBOXAMIDE)-1,4-PIPERAZINE 
2.6.1 Materials and Methods 
N,N′-bis(2-pyridinecarboxamide)-1,4-piperazine (2.13) was prepared according to a literature 
procedure.68  Triphenyl phosphite (d = 1.184 g/mL, 30.40 mL, 0.116 mol) was added slowly to a 
solution of picolinic acid (14.29 g, 0.116 mol) and 1,4 piperazine (5.00 g, 0.0580 mol) in dry 
pyridine (47.0 mL). After four hours of stirring at 100 °C the reaction mixture was allowed to sit 
at room temperature for several days until crystals formed. White crystals were collected by 
vacuum filtration. Recrystallization several times from dimethylsulfoxide yielded X-ray quality 
crystals.  1H NMR (300 MHz, DMSO-d6, δ):   8.58 (dd, 2H, H-1), 7.93 (m, 2H, H-3), 7.61 (m, 
2H, H-4), 7.48 (m, 2H, H-2), 3.75 (s, 2H, H-8), 3.66 (m, 2H, H-7), 3.53 (m, 2H, H-6), 3.44 (s, 
2H, H-5); 13C{H} (125 MHz, DMSO-d6 δ): 166.86 (C=O), 153.63 (Py-ipso), 148.40 (C-1), 
148.31 (C-1′), 137.46 (C-3, C-3′), 124.78 (C-4), 123.40 (C-2), 46.83 (C-5), 46.24 (C-6), 41.95 
(C-7), 41.40 (C-8); ESI-MS M+ 298 
 
Reaction with [Ru(NO)Cl3(H2O)2]:  The reaction between 2.13 and [Ru(NO)Cl3(H2O)2] was 
run according to a modified literature procedure.69 Trichloronitrosylruthenium (0.0018 mol, 
0.500 g) was added to a ethanol/water (95%, 40.0 mL) solution of N,N′-bis(2-
pyridinecarboxamide)-2,4-piperazine (0.447 g, 0.0015 mol, 1 equiv) with stirring. The reaction 
mixture was stirred for ten hours at 85.0 °C.  A brown precipitate was isolated from the reaction 
mixture. 
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The filtrate was left for slow evaporation of solvent at room temperature for crystal formation.  
The color change and precipitate formation indicate that a reaction has occurred.  However, 
isolation and characterization of the products is pending. 
2.6.2 Results and Discussion 
The ligand N,N′-bis(2-pyridinecarboxamide)-1,4-piperazine (2.13) was prepared and 
characterized by 13C and 1H NMR spectroscopy.  The labeling scheme for NMR chemical shift 
assignments is shown in Figure 2.20.  1H  and 13C NMR assignments can be seen in Tables 2.13 
and 2.14, respectively.  The respective 1H signals for each pyridyl moiety exhibit the same 
chemical shift values. The aryl portion of the 1H NMR spectrum can be seen in Figure 2.21   
.The 13C signals  are approximately the same for each pyridyl moiety, C-1 for one pyridyl moiety 
resonates at 148.40 while C-1′ resonates at 148.31; two very closely spaced  signals also occur 
for C-3 and C-3′.   
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Figure  2.20-N,N′-bis(2-pyridinecarboxamide)-1,4-piperazine 
                      Table  2.14-1H NMR Data for N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine 
1H 1 2 3 4 5 6 7 8 
2.13 8.58 7.48 7.93 7.61 3.44 3.53 3.66 3.75 
                          
                    Table  2.15-13C NMR Data for N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine  
        13C 1 2 3 4 Py-ipso C=O 5 6 7 8 
2.13 148.40 124.78 137.46 46.83 153.63 166.86 46.83 46.24 41.95 41.48 
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Figure  2.21-Aryl region of 1H NMR spectrum of 2.13 
 
 
The X-ray structure of N,N′-bis(2-pyridinecarboxamide)-1,4-piperazine can be seen in 
Figure 2.22. Crystal intensity and collection data are reported in Table 2.16. Selected bond 
distances and angles are shown in Table 2.17. There is some variation in bond angles for the 
piperazine ring. The N(2)-C(9)-C(10) angle is larger than the N(3)-C(8)-C(7) angle while the 
C(9)-C(10)-N(3) angle is slightly larger than the N(2)-C(8)-C(7) angle. The angles that include 
the pyridine nitrogen also vary slightly with the N(4)-C(12)-C(11) angle being larger than the 
corresponding N(1)-C(5)-(6) angle. 
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Table  2.16-Crystal data and refinements for 2.13 
  2.13 
Chemical Formula C144H176N32O24
Formula Weight 2995.65 
Temperature (K) 150(2) 
Wavelength (Å) 0.71073 
Crystal system Triclinic 
Space group P-1 
a (Å) 10.4724(9) 
b (Å) 18.2261(15) 
c (Å) 19.9367(14) 
α (°) 90 
β (°) 108.922(4) 
γ (°) 90 
Volume (Å3) 3599.7(5) 
Z 1 
Density (calculated) Mg/m3 1.382 
Absorption Coefficient (mm-1) 0.206 
F(000) 1584 
Crystal Size (mm3) 0.27 x 0.22 x 0.22 
θ range for data collection (°) 1.55 to 27.50 
Index Ranges -13 ≤ h ≤ 13 
 -23 ≤ k ≤ 23 
 -25 ≤ l ≤ 25 
Reflections collected 34838 
Independent reflections 8264 [R(int) = 0.0260] 
Completeness 100 % (θ =27.50°) 
Data / restraints / parameters 8264/ 0 / 469 
Max. and min. transmissions 0.9560 and 0.9464 
Refinement Method Full-matrix least-squares on F2
Goodness-of-fit on F2 0.934 
Final R indices[I > 2σ (I)] R1 = 0.0753, wR2 = 0.1797 
R indices (all data) R1 = 0.1450, wR2 = 0.2100 
Largest diff. peak and hole (e  Å3) 1.465 and -0.266 
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2.13 
Figure  2.22-X-ray structure of N,N′-bis(2-pyridinecarboxamide)-1,4-piperazine  
 
Table  2.17-Selected Bond Lengths and Angles for 2.13 
 
O(1)-C(6) 1.232(5) O(2)-C(11) 1.232(5) 
N(3)-C(11) 1.344(5) N(2)-C(6) 1.342(5) 
N(3)-C(8) 1.472(5) N(2)-C(9) 1.457(5) 
C(7)-C(8) 1.512(5) C(9)-C(10) 1.482(6) 
N(2)-C(7) 1.485(5) N(3)-C(10) 1.484(5) 
C(11)-C(12) 1.513(5) C(5)-C(6) 1.510(6) 
    
N(4)-C(12)-C(11) 119.2(3) N(1)-C(5)-C(6) 117.7(3) 
N(3)-C(11)-C(12) 119.4(4) N(2)-C(5)-C(6) 119.5(4) 
N(3)-C(8)-C(7) 108.9(3) C(9)-C(10)-N(3) 109.4(4) 
N(2)-C(8)-C(7) 108.8(3) N(2)-C(9)-C(10) 110.6(4) 
C(16)-N(4)-C(12) 117.2(3) N(1)-C(5)-C(6) 117.7(3) 
 
 
 
 
 
 
  
Although the tetradentat compound (2.14) shown in Figure 2.24 has not been isolated. A 
color change, precipitate formation and preliminary NMR data from the reaction between 2.13 
and [Ru(NO)Cl3(H2O)2] suggest the formation of at least one new species.  The aryl region of the 
300 MHz NMR spectrum of the reaction mixture is shown in Figure 2.25. 
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                                              Figure  2.23-Tetradentate RuNO complex  
 
 
 
 
 
Figure  2.24-1H NMR Spectrum of reaction mixture from 2.13 with [Ru(NO)Cl3(H2O)2] 
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2.6.3 Conclusion 
The ligand, N,N′-bis(2-pyridinecarboxamide)-1,4-piperazine has been synthesized and 
characterized by NMR spectroscopy and X-ray crystallography.  Preliminary NMR results 
suggest formation of at least one new species upon reaction of [Ru(NO)Cl3(H2O)2] with 2.13.   
2.7 GENERAL CONCLUSION 
The ligands N,N′-bis(2pyridinecarboxamide)-1,2-benzene, N,N′-bis(2pyridinecarboxamide)-2,3- 
diaminopyridine, N,N′-bis(2pyridinecarboxamide)-3,4-diaminopyridine, N,N′-
bis(2pyridinecarboxamide)-1,2-ethane, N,N′-bis(2pyridinecarboxamide)-1,3-propane, and 
N,N′-bis(2pyridinecarboxamide)-1,4-piperazine were prepared and characterized by 13C and 1H NMR 
spectroscopy and/or X-ray crystallography.  The ligands were allowed to react with 
[Ru(NO)Cl3(H2O)2] to form complexes that might facilitate RuNO transport through the body. The 
carboxamido groups were included to enhance solubility, activate the nitrosyl moiety to photolytic loss 
of NO• and then stabilize the RuIII-solvent complex that remains after photolysis.  The pyridyl arms 
are intended to ensure chelation to the RuII center.   
The first ligand, N,N′-bis(2pyridinecarboxamide)-1,2-benzene, coordinated to the RuNO 
center in the equatorial plane as expected. The complex is formally {RuIINO+}6 as determined by 
the NO stretching frequency of 1867 cm-1. A crystal structure of the ruthenium nitrosyl complex 
obtained by the Mascharak group reveals a linear nitrosyl with an Ru-N-O angle of 172.37(14)°. 
Photochemical experiments confirmed photolysis NO• under UV light.26  
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The second ligand, N,N′-bis(2-pyridinecarboxamide)-2,3-diaminopyridine, differs from 
N,N′-bis(2pyridinecarboxamide)-1,2-benzene, in that the aromatic backbone is 2,3-
diaminopyridine, rather than 1,2 diamino benzene.  Introduction of the pyridine moiety changes 
the reactivity of the ligand such that coordination to RuII occurs through a carbonyl oxygen atom 
and through one pyridine nitrogen.  The uncoordinated ligand is pendant.  X-ray crystallography 
reveals that the two RuNO complexes result from the same coordination mode.  One complex 
has an Ru-N-O angle of 177.5(9) the other, 172.9(10). Another interesting feature about the 
complexes that result from this binding mode is the chloride ions are in the equatorial plane.  For 
all of the other complexes characterized in this series, a chloride atom is trans to NO.  
Unfortunately, no IR data are available at this time.  However, the slight difference in N-O bond 
for each isomer suggests that each will exhibit unique N-O stretching frequency, at least in the 
solid state.  It remains to be seen if this coordination mode will facilitate NO transport and 
photolysis.  Regardless, there are some possible benefits to this coordination mode.  The 
uncoordinated portion of the ligand is available to either coordinate to another Ru-NO moiety or 
even to a different metal.  The pendant carboxamido and pyridyl groups might also provide a 
means to anchor the complex to a biologically active site. Another product which seems to be 
coordinated through only one carboxamido nitrogen and one pyridyl group has also been 
isolated. This complex also offers the potential to coordinate to another metal center or to some 
bioliogically active site.  Although the tetradentate coordinated complex has not been isolated, its 
presence in the reaction mixture has not been ruled out.  If it is isolated the difference in the 
electron-donating abilities of the carboxamido nitrogen atoms are likely to introduce some 
interesting reactivity to the complex.  Isolation of complexes with various coordination modes 
will reveal much about this ligand’s influence on the Ru-NO moiety. 
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The third ligand, N,N′-bis(2pyridinecarboxamide)-3,4-diaminopyridine, was 
characterized by 13C and 1H NMR spectroscopy.  The ligand exhibits the same differences in 13C 
NMR chemical shift for the carboxamido bearing nitrogen atoms but in the opposite sense. 
Unfortunately, the product from the reaction between the ligand and [Ru(NO)Cl3(H2O)2] were 
not isolated in time for this report.  However, if the complex follows the same trend at the 2,3-
diaminopyridine derivative then similar coordination modes that reflect the difference in position 
of the pyridine nitrogen in the ligand backbone might be observed.  
The fourth ligand, N,N′-bis(2pyridinecarboxamide)-1,2-ethane, has an alkyl backbone 
instead of an aromatic backbone.  A crystal structure was obtained for the RuNO complex. The 
complex exhibits a linear Ru-NO bond with and angle of 177.0(4)° and N-O bond length of  
1.140(5). The N-O infrared stretching frequency is 1825 cm-1.  
The fifth ligand, N,N′-bis(2pyridinecarboxamide)-1,3-propane, has an additional carbon 
in the the alkyl backbone and introduces some variation in the bite angles with respect the ethane 
derivative.  The crystal structure of the RuNO complex reveals a linear Ru-N-O angle and N-O 
bond distance similar to the ethane derivative.  The N-O infrared stretching frequency at  
1838 cm-1 is higher than that of the ethane derivative and might be a function of bite angle. The 
protons on the backbone of the alkyl derivative seem to be good reporters of the magnetic 
anisotropy presented by the Ru-NO moiety.  The 1H NMR signals for the protons on the 
backbone each alkyl derivative are differentiated by their position with respect to the central 
metal. Derivatization at the central carbon might provide more information and also provide an 
anchoring site for biological molecules. 
A crystal structure for the final ligand in this series, N,N′-bis(2pyridinecarboxamide)-1,4-
piperazine was obtained.  While the product(s) from the reaction between the ligand and 
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[Ru(NO)Cl3(H2O)2] were not isolated, 1H  NMR analysis suggest formation of at least one new 
product. If tetradentate coordination occurs, the orientation two piperazine ethylene chains 
should provide more information about the magnetic anisotropy about the Ru-NO moiety as well 
as provide sites for derivatization.  Comparison of NMR data for the Ru-NO complex and the 
ligand will provide information about the distortion introduced to the ligand upon coordination. 
In summary, the reaction between [Ru(NO)Cl3(H2O)2] and the ligands described yield 
complexes that may facilitate Ru-NO transport to tumor cells. Slight variations in the ligand 
backbone in some cases seems exert a strong influence of the ligand’s coordination preference. 
The differences in coordination mode should translate into a different influence on photolytic 
activity. Based up the IR stretching frequencies of the NO moiety, the complexes that have been 
characterized seem to donate electron density to differing degrees to the Ru-NO moiety. 
Photolysis data can now be correlated with these differences in the coordination environment. 
Comparison the difference in the NMR spectra of the Ru-NO complex and the photolysis 
product can also provide interesting insights into the nitrosyl group’s influence on the ligand.  
 
 63 
3.0  BIS-PYRAZINE BIS-CARBOXAMIDO LIGANDS 
In order to systematically vary the ligand environment, another set of ligands, with the same 
benzene, 2,3-diaminopyridine, 3,4-diaminopyridine, diaminoethane, 1,3-diaminopropane and 
1,4-piperazine backbones was prepared with pyrazine instead of pyridine.  Pyrazine is less of a σ 
base than is pyridine due to the extra nitrogen in the pyrazine ring.  In addition, pyrazine is a 
more efficient π acceptor for the same reason.  This variation will allow a comparison of the 
influence on NO photolability for pyrazine and pyridine.  Incorporation of pyrazine also may 
change solubility and allow for bridging coordination between other metal centers.  Recently 
pyrazine bridged ruthenium nitrosyl complexes were shown to release NO under visible light.80 
3.1 N,N′-BIS(2-PYRAZINECARBOXAMIDE)-1,2-BENZENE 
3.1.1 Materials and Methods 
N, N′ -bis(2-pyrazinecarboxamide)-1,2-benzene (3.1) was prepared according to a modified 
literature procedure.68  1,2-Diaminobenzene (2.00 g, 0.0184  mol) was added to a stirred solution 
of pyrazine carboxylic acid (4.55 g,  0.369 mol) in dry pyridine (18.0 mL).  After triphenyl 
phosphite  (310.29 g/mol, d = 1.184 g/mL, 9.69 mL) was added slowly, the reaction mixture was 
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stirred at 100 °C in an oil bath for four hours. White crystals were obtained after the reaction 
mixture was left standing at ambient temperature overnight.  Recrystallization from chloroform 
afforded X-ray quality crystals.  1H NMR (500 MHz, DMSO-d6): δ 10.7 (s, 2H, N-H(1), N-
H(2)), 9.30 (s, 2H, H-3), 8.91 (d, 2H, H-2), 8.75 (d, 2H, H-1), 7.75 (m, 2H, H-4), 7.33 (m, 2H, 
H-5).  13C{1H} 1H NMR, DMSO-d6):  δ 161.84 (C=O), 148.02 (C-2), 144.29 (Pz-ipso), 143.93 
(C-3), 143.39 (C-1), 130.61(Ar-ipso), 126.35 (C-5), 125.98 (C-4);  ESI-MS M+. =  320 
 
Chloro-nitrosyl-N,N′-bis(2-pyrazinecarboxamido)-1,2-benzene (3.2) was prepared according 
to a modified literature procedure.69 Trichloronitrosylruthenium (0.0018 mol, 0.500 g) was added 
to a stirred solution of N,N′-bis(2-pyrazinecarboxamide-1,2-benzene in an ethanol/water solution 
(95%, ~50.0 mL).  The reaction mixture was stirred at 65.0-70.0 °C for twelve hours.  A fine 
brown precipitate was filtered from the reaction mixture and rinsed with ethanol.  1H NMR (500 
MHz, DMSO-d6): δ 9.43 (m, 2H, H-2), 9.34 (s, 2H, H-3), 9.26 (d, 2H, H-1), 8.53 (m, 2H, H-7), 
7.09 (m, 2H, H-8,);  13C{1H} 1H NMR, DMSO-d6):  δ 162.45 (C-5), 151.25 (Pz-ipso), 149.27 
(C-1), 147.22 (C-3), 146.27 (C-2), 143.38 (Ar-ipso), 124.22 (C-8), 121.03 (C-7);  ESI-MS M+. =  
320 
3.1.2 Results and Discussion 
Table 3.1 shows the 1H and 13C assignments for 3.1 and 3.2; the labeling scheme is in Figure 3.1.  
1H and 13C assignments were made based upon HH COSY, HMQC, and HMBC spectra.  
Disappearance of the amide N-H upon coordination indicates chelation by the phenylenediamine 
moiety.  The upfield shift of the pyrazyl 1H resonances and all but C-2 of the 13C resonances 
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indicate coordination of the pyrazyl groups.  The most affected protons on the pyrazyl ring 
correspond to H-1 and H-2;  H-3 is barely affected.  The most significantly affected protons are 
H-4 which are adjacent to the nitrogen-bearing carbons on the benzene ring.  H-5 protons exhibit 
a slight upfield shift. 
The 1H and 13C spectra for the ligand, 3.1, are very similar to that of the pyridine 
analogue, 2.2.  The pyrazine 1H resonances are more downfield than the corresponding pyridyl 
resonances for 2.2; the aryl 1H resonances are almost exactly the same. As expected, the 13C 
chemical shift values are more sensitive to the additional nitrogen atom in the pyrazine ring. All 
pyrazine 13C resonances, except for the pyrazine-ipso carbon are downfield with respect to the 
corresponding pyridyl resonances. The pyrazine-ipso carbon is actually more shielded than the 
corresponding carbon in 2.2. The aryl 13C resonances and the carbonyl resonance are about the 
same for 3.1 and 2.2. 
The RuNO complex, 3.2, is also similar to the pyridine analogue, 2.3. 1H resonances for 
3.2 are slightly downfield from the corresponding pyridyl resonances for 2.3. The major 
difference is seen for H-2.  H-2 for 3.2 resonates at 9.43 ppm; H-2 for 2.3 gives a signal at 7.94 
ppm. A similar difference is seen for the ligands.  Again, the 13C NMR spectrum is more 
sensitive to the changes introduced by the nitrogens in the pyrazine ring.  C-1 of Complex 2.3 
resonates at 152.49 ppm while the corresponding resonance for 3.2 appears at 149.27.  However, 
the downfield shift for C-1 of 3.2 is greater than that for 2.3 upon coordination to RuNO. The 
pyrazine ipso carbon in 3.2 is less downfield shifted upon coordination than is the pyridine ipso.  
That C-2 of 3.2 resonates 18.22 ppm downfield from C-2 of 2.3 is attributed to the adjacent 
pyrazine nitrogen.  A similar difference is seen between the ligands. However, C-2 for 3.2 shifts 
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upfield 1.75 ppm upon coordination while C-2 for 2.3 shifts downfield only 0.95 ppm.     All 
other changes in 13C resonances are of similar magnitude and in the same direction. 
 The crystal structure for 3.1 is shown in Figure 3.2. Crystal intensity and collection data 
are shown in Table 3.2. Selected bond lengths and angles are presented in Table 3.3. As of this 
time, no crystal structure has been obtained for the complex 3.2.  The crystal structures for 2.2 
and for 2.3 have been published by others.26,70  Since a crystal structure for 3.2 has not been 
obtained the crystal structure of 3.1 will not be discussed here.   
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       Figure  3.1-N,N′-bis(2-pyrazinecarboxamide)-1,2-benzene  and RuNO complex  
 
Table  3.1-1H and 13C NMR data for 3.1 and 3.2 
 
1H 1 2 3 4 5 N-H    
3.1 8.75 8.91 9.30 7.75 7.33 10.7    
3.2 9.26 9.43 9.34 8.53 7.09 *    
13C       Ar-ipso Pz-ipso C=O 
3.1 143.39 148.02 143.93 125.64 126.01 * 130.61 144.29 161.84 
3.2 149.27 146.27 147.22 121.03 124.22 * 143.38 151.25 162.45 
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                                     Table  3.2-Crystal data and refinements for  3.1 
 
 3.1 
Chemical Formula C16H12N6O2
Formula Weight 320.32 
Temperature (K) 295(2) 
Wavelength (Å) 0.71073 
Crystal system Monoclinic 
Space group P2(1)/c 
a (Å) 11.4639(11) 
b (Å) 9.5090(9) 
c (Å) 14.6602(14) 
α (°) 90 
β (°) 110.687(2) 
γ (°) 90 
Volume (Å3) 1495.1(2) 
Z 4 
Density (calculated) Mg/m3 1.423 
Absorption Coefficient (mm-1) 0.100 
F(000) 664 
Crystal Size (mm3) 0.37 x 0.34 x 0.12 
θ range for data collection (°) 1.90 to 25.00 
Index Ranges -13 ≤ h ≤ 13 
 -11 ≤ k ≤ 11 
 -17 ≤ l ≤ 17 
Reflections collected 11775 
Independent reflections 2641 [R(int) = 0.0448] 
Completeness 100 % (θ =25.00°) 
Data / restraints / parameters 2641/ 0 /265 
Max. and min. transmissions 0.9881 and 0.9639 
Refinement Method Full-matrix least-squares on F2
Goodness-of-fit on F2 1.229 
Final R indices[I > 2σ (I)] R1 = 0.0619, wR2 = 0.1364 
R indices (all data) R1 = 0.0926, wR2 = 0.1453 
Largest diff. peak and hole (e  Å3) 0.151 and -0.213 
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 Figure  3.2-N,N′-bis(2-pyrazinecarboxamide)-1,2-benzene  
 
Table  3.3-Selected bond lengths and angles for 3.1 
 O(1)-C(5) 1.215(3) O(2)-C(12) 1.203(3) O(1)-C(5)-N(3) 123.2(3) 
N(3)-C(5) 1.349(3) N(4)-C(12) 1.342(3) O(2)-C(12)-N(4) 125.2(3) 
C(4)-C(5) 1.491(3) C(12)-C(13) 1.493(4) O(1)-C(5)-C(4) 121.4(2) 
N(3)-C(6) 1.431(3) N(4)-C(11) 1.405(3) O(2)-C(12)-C(13) 121.1(3) 
N(1)-C(1) 1.331(3) N(6)-C(16) 1.331(4) N(1)-C(4)-C(5) 118.5(2) 
N(1)-C(4) 1.325(3) N(6)-C(13) 1.330(3) N(6)-C(13)-C(12) 118.5(2) 
C(1)-C(2) 1.367(4) C(15)-C(16) 1.363(4) N(3)-C(5)-C(4) 115.4(2) 
N(2)-C(2) 1.312(4) N(5)-C(15) 1.326(4) N(4)-C(12)-C(13) 113.7(2) 
N(2)-C(3) 1.334(4) N(5)-C(14) 1.329(4) C(3)-C(4)-C(5) 119.5(3) 
C(3)-C(4) 1.373(4) C(13)-C(14) 1.380(4) C(14)-C(13)-C(12) 120.0(3) 
C(6)-C(11) 1.395(3) C(8)-C(9) 1.364(4) C(11)-C(6)-N(3) 119.9(2) 
C(10)-C(11) 1.390(4) C(6)-C(7) 1.380(4) C(6)-C(11)-N(4) 118.2(2) 
C(7)-C(8) 1.384(4) C(9)-C(10) 1.371(4) C(6)-C(7)-C(8) 120.2(3) 
    C(8)-C(9)-C(10) 120.8(3) 
    C(10)-C(11)-C(6) 118.6(3) 
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3.1.3 Conclusion  
The pyrazine analogue of N,N′-bis(2-pyridinecarboxamide)-1,2-benzene (2.2), N,N′-bis(2-
pyrazinecarboxamide)-1,2-benzene (3.1) was prepared and characterized by 1H NMR and 13C 
NMR spectroscopy and X-ray crystallography.  The corresponding ruthenium nitrosyl complex 
was prepared (3.2).  NMR data indicate that the ligand coordinated through the pyrazine nitrogen 
atoms and the deprotonated carboxamido nitrogen atoms in the equatorial plane.  Comparison of 
the NMR data for the ligand and complex to the pyridine suggests that the pyrazine moiety 
introduces some variations that will require further analysis to explain.   
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3.2 N,N′-BIS(2-PYRAZINECARBOXAMIDE)-2,3-PYRIDINE 
3.2.1 Materials and Methods 
N,N′-bis(2-pyrazinecarboxamide)-2,3-pyridine (3.3) was prepared according to a modified 
literature procedure.68 Pyrazinecarboxylic acid (1.23 g, 0.010 mol) was dissolved in dry pyridine 
(~ 5.0 mL).  To the picolinic acid solution was added 2,3-diaminopyridine (109.13 g/mol, 0.548 
g, 0.005 mol) and triphenyl phosphite (d = 1.184 g/mL, 2.63 mL, 0.010 mol).  The reaction 
mixture was stirred at 100 °C for four hours.  Upon standing at room temperature for 5 days the 
reaction mixture produced crystals in a thick dark brown mixture.  An attempt to isolate the 
crystals by vacuum filtration failed because the viscous pyridine solution clogged the frit.  The 
product crystals were taken up in dichloromethane and combined with the filtrate.  Most of the 
viscous brown portion of the reaction mixture remained on the frit.  After the filtrate volume was 
reduced by rotary evaporation (~ 40 °C) the filtrate was added dropwise to diethyl. A yellow 
precipitate was isolated by vacuum filtration.  The filtrate was left at room temperature for a 
second crop.  The procedure was repeated until no more product precipitated.  The product was 
obtained in low but undetermined yield.  1H NMR (600 MHz, dimethylsulfoxide-d6): δ 11.09 (s, 
1H, N-H (2)), 10.63 (s, 1H, N-H(2)), 9.31 (d, 2H, H-15, H-1), 8.95 (d, 1H, H-14), 8.91 (d, 1H, 
H-2), 8.82 (td, 1H, H-13), 8.74 (td, 1H, H-3), 8.38 (dd, 1H, H-9), 8.36 (dd, 1H, H-7); 13C{1H} 1H 
NMR, dimethyl sulfoxide-d6):  δ 162.70 (C-11), 161.66 (C-5), 148.26 (C-14, C-2), 145.26 (C-9), 
144.11 (C-12), 144.06 (C-4), 143.88 (C-15), 143.82 (C-1), 143.61 (C-13), 143.50 (C-3), 127.85 
(C-6), 133.48 (C-7), 142.92 (C-10), 122.50 (C-8);  ESI-MS M+. = 321  
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Reaction with [Ru(NO)Cl3(H2O)2]: The reaction between 3.3 and [Ru(NO)Cl3(H2O)2] was 
carried out according to a modified literature procedure.69 Trichloronitrosylruthenium (0.135g, 
0.00049 mol) was added to ethanol/water solution (95%, ~40.0 mL, 80.0 °C) of N,N′-bis(2-
pyrazinecarboxamide)-2,3-pyridine (0.159 g, 0.00049 mol).  An additional 20.0 mL of the 
ethanol/water solvent was used to transfer the [Ru(NO)(Cl3)(H2O)2].  The reaction mixture 
became orange and a precipitate formed immediately.  The reaction mixture was stirred at 80.0 
°C for seven hours.  A brown precipitate was removed from the reaction mixture by vacuum 
filtration.  The filtrate volume was reduced under vacuum (rotary evaporator, 55 °C).  The filtrate 
was stored at room temperature to allow for slow evaporation of solvent. 
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3.2.2 Results and Discussion 
The labeling scheme for the ligand, N,N′-bis(2-pyrazinecarboxamide)-2,3-pyridine (3.3) 
is shown in Figure 3.3.  1H and 13C assignments are show in Tables 3.4 and 3.5, respectively.  
Chemical shift assignments were made based upon HH COSY, HMQC, and HMBC spectra.  As 
for 2.4 the instruction of the pyridine into the backbone of the ligand differentiates the pyrazyl 
arms for 3.3.  Resonance forms of the pyridine ring in 3.3 places positive charge on the carbon 
atoms ortho and para to the pyridine nitrogen.  For 3.3 C-10 exhibits more of a positive character 
than does C-6 as shown by the 13C NMR data.  The signal for C-10 is at 142.92 ppm while that 
for C-6 is at 127.85 ppm.  The remaining 1H and 13C signals within 3.3 differ only slightly from 
each other.  
The 1H NMR spectrum of the aryl region of the 3.3 is shown in Figure 3.5. The 
tetradentate ruthemium nitrosyl complex (3.4) has not yet been isolated from the reaction 
mixture. 1H NMR spectrum of the aryl region of the crude reaction mixture, shown in Figure 3.6, 
suggests that more than one product has formed.     
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Figure  3.3- N,N′-bis(2-pyrazinecarboxamide)-2,3-pyridine 
 
 
Table  3.4- 1H Resonances for N,N′-bis(2-pyrazinecarboxamide)-2,3-pyridine 
1H 1 2 3 7 8 9 13 14 15 N-H(1) N-H(2) 
3.3 9.31 8.91 8.74 8.36 7.48 8.38 8.82 8.95 9.31 10.63 10.97 
 
 
Table  3.5-13C Resonances for N,N′-bis(2-pyrazinecarboxamide)-2,3-pyridine 
 13C 1 2 3 4 5 6 7 8 9 10 
3.3 143.82 148.26 143.50 144.06 161.66 127.85 133.48 122.50 145.26 142.92 
           
3.3 11 12 13 14 15      
 162.70 144.11 143.61 148.26 143.88      
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Figure  3.4-Tetradentate ruthenium nitrosyl compound  
 
 
 
Figure  3.5- 1H NMR spectrum of aryl region of 3.3 
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 Figure  3.6-1H NMR spectrum of aryl region after reaction of  3.3 with [Ru(NO)Cl3(H2O)2] 
 
3.2.3 Conclusion 
The ligand, 3.3, shows 1H and 13C NMR chemical shift patterns similar to those of 2.4, the 
pyridine analogue. While no conclusion regarding the new compound(s) from the reaction 
between [Ru(NO)Cl3(H2O)2] and 3.3, can be drawn at this time, the 1H NMR spectrum does 
indicate formation of more than one product.  The signals near 12 ppm could correspond to the 
N-H protons; the presence of N-H resonances suggests that ligand 3.3 might chelate through the 
carbonyl oxygen and through one pyrazine nitrogen atom as did 2.4.   
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3.3 N,N′-BIS(2-PYRAZINECARBOXAMIDE)-3,4-PYRIDINE 
3.3.1 Materials and Methods 
N,N′-bis(2-pyrazinecarboxamide)-3,4-pyridine (3.5) was prepared according to a modified 
literature procedure.68 Pyrazinecarboxylic acid (1.13 g, 0.009 mol) was dissolved in dry pyridine 
(~ 5.0 mL).  To the picolinic acid solution was added 2,3-diaminopyridine (0.502 g, 0.005 mol) 
and triphenyl phosphite (d = 1.184 g/mL, 2.40 mL).  The reaction mixture was stirred at 100 °C 
for four hours.  Upon standing at room temperature for 1 day the reaction mixture produced 
crystals in a thick orange/brown mixture. 1H   After several days, the mixture was vacuum 
filtered and rinsed with chloroform.  A viscous liquid remained on the frit.  The filtrate volume 
was reduced under vacuum. The concentrated filtrate was left standing at room temperature.  The 
viscous liquid from the frit was also dissolved with chloroform and stored in a separate beaker.  
After several days crystals formed in the filtrate and were isolated by vacuum filtration, rinsed 
and recrystallized from ethanol or chloroform. ESI-MS M+. = 321.  Preliminary 300 MHz 1H 
NMR results suggest that formation of 3.5.  The 1H NMR spectrum can be seen in Figure 3.8. 
 
N,N′-bis(2-pyrazinecarboxamide)-3,4-pyridine reaction with [Ru(NO)Cl3(H2O)2] The 
reaction was run according to a modified literature procedure.69 Trichloronitrosylruthenium 
(0.106 g, 0.00039 mol) in ethanol/water (95%, 10.0 mL) was added by pipette to an 
ethanol/water solution (95%, ~15.0 mL, 80.0 °C) of N,N′-bis(2-pyrazinecarboxamide)-3,4-
pyridine (0.125 g, 0.00039 mol).  The reaction mixture became orange and a precipitate formed 
upon addition of  [Ru(NO)(Cl3)(H2O)2].  The reaction mixture was stirred at 80.0 °C for six 
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hours.  A brown precipitate was removed from the reaction mixture by vacuum filtration.  The 
filtrate volume was reduced under vacuum (rotary evaporator, 55 °C).  The filtrate allowed to 
evaporate slowly at room temperature to induce precipitation or crystallization. Eventually a tan 
solid was obtained.  Comparison of the 1H NMR spectrum with that of the starting material 
suggests the presence of one new species.   
 
3.3.2 Results and Discussion 
Mass spectral analysis confirmed the successful preparation of 3.5. Final NMR assignments 
await 500 MHz two- dimensional data acquisition. However, preliminary 300 MHz 1H NMR 
data indicates isolation of a single product with some NMR signals characteristic of similar N,N′-
bis(2-pyridinecarboxamide)-3,4-pyridine and of N,N′-bis(2-pyrazinecarboxamide)-2,3-pyridine.  
The only signals that can be assigned with certainty at this time are the N-H(1) resonance at 
11.04 ppm and the N-H(2) resonance at 10.72 (Figure 3.8). 
The reaction between 3.5 and [Ru(NO)Cl3(H2O)2] yielded at least one new product. 
Comparison of the 300 MHz 1H NMR spectrum of the new product to that of 3.5 indicates 
isolation of a single product.  Unfortunately the mass spectral analysis was inconclusive and 
must be repeated.                                                           
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Figure  3.7-N,N′-bis(2-pyrazinecarboxamide)-3,4-diaminopyridine   
           
Figure  3.8-1H NMR spectrum of aryl region of 3.5 and isolated product 
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3.3.3 Conclusion 
Although characterization of the ruthenium nitrosyl compound isolated from the reaction 
between N,N′-bis(2-pyrazinecarboxamide)-3,4-diaminopyridine has not been completely 
characterized, comparison of the 1H NMR spectrum of the isolated product to that of the ligand 
suggests that the ligand is coordinated in tetradentate fashion by the two carboxamido nitrogen 
atoms and the two pyridyl arms.  Other spectra, not shown, suggest the presence of other 
coordination modes. 
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3.4 N,N′-BIS(2-PYRAZINECARBOXAMIDE)-1,2-ETHANE 
3.4.1 Materials and Methods 
N,N′-bis(2-pyrazinecarboxamide)-1,2-ethane (3.6) was prepared according to a modified 
literature procedure.68 A solution diaminoethane (d = 0.899 g/mL, 0.481 g, 0.540 mL, 0.008 mol) 
in dry dimethylformamide (~ 4.0 mL) was added to  a solution of pyrazinecarboxylic acid (2.00 
g, 0.016 mol), in dry dimethylformamide (~15.0 mL). A white precipitate formed upon addition 
of the diamine. The reaction mixture was stirred as triphenyl phosphite (d = 1.184 g/mL, 4.96 g, 
0.016 mol) was added by pipette.  The white precipitate did not dissolve after four hours of 
stirring at 110.0 °C.  Additional dry dimethylformamide (~ 180 mL) was added.  The precipitate 
dissolved after two more hours at 110.0 °C.  The reaction mixture was stirred for four more 
hours at 110.0 °C.  In total the reaction mixture required 200.0 mL dimethylformamide and eight 
hours of stirring at 110.0 °C.  After solvent volume was reduced under vacuum the reaction 
mixture was allowed sit for a few days during which a solid formed.  The white solid turned to a 
paste during vacuum filtration.  The paste was taken up in dry chloroform. After the chloroform 
solution was dried over magnesium sulfate, slow evaporation of solvent produced crystals of 
N,N′-bis(2-pyrazinecarboxamide)-1,2-ethane.  Repeated recrystallization from chloroform was 
required to obtain a pure product. Yield: 1.05 g, 48% yield; 1H NMR (500 MHz, DMSO-d6, δ):  
9.16 (s, 2H, H-3, H-10), 9.09 (t, 2H, N-H(1), N-H(2)), 8.85 (d, 2H, H-1, H-12), 8.71 (d, 2H, H-2, 
H-11), 3.52 (m, 4H, H-6, 6′, H-7, 7′)13C{H} (125 MHz, DMSO-d6) δ):  163.16 (C=O), 147.41 
(C-2), 144.73 (Pz-ipso), 143.26 (C-1), 38.73 (C-4, C-5);  ESI-MS M+. = 272. 
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Chloro-nitrosyl-N,N′-bis(2-pyrazinecarboxamido)-1,2-ethane (3.7) was prepared 
according to a modified literature procedure.69 Trichloronitrosylruthenium (0.0018 mol, 0.502 g 
was added to ethanol/water solution (50%, ~100.0 mL, 80.0 °C) of N,N′-bis(2-
pyrazinecarboxamide)-1,2-ethane (272.26 g/mol, 0.500 g, 0.0018 mol).  After the reaction 
mixture was stirred for eight hours a fine brown precipitate was removed from the reaction 
mixture.  The filtrate volume was reduced to ~ 15.0 mL under vacuum (rotary evaporator).  After 
several days at ambient temperature the filtrate yielded red crystals of the product. Crystals have 
been submitted for X-ray analysis.  1H NMR (500 MHz, DMSO-d6,  δ): 9.41 (m, 2H, H-1), 9.24 
(bs, 2H, H-2), 9.23 (bs, 2H, H-3), 4.09 (m, 2H, H-4′, H-5), 3.92 (m, 2H, H-4, H-5′);   13C{H} 
(125 MHz, DMSO-d6) δ): 166.26 (C=O), 151.21 (pz-ispso), 149.63 (C-2), 147.07 (C-3), 146.89 
(C-1),  52.18 (C-4, C-5); IR (KBr): v N O  = 1850 cm ; ESI-MS M  = 436.78 -1 +.
3.4.2 Results and Discussion 
Figure 3.9 shows the labeling scheme for the ligand, N,N′-bis(2-pyrazinecarboxamide)-1,2-
ethane (3.6) and its ruthenium nitrosyl complex, chloro-nitrosyl-N,N′-bis(2-
pyrazinecarboxamido)-1,2-ethane ruthenium(II) (3.7).  13C and 1H NMR data are shown in Table 
3.6.  All chemical shift assignments were made based upon HH COSY, HMQC and HMBC 
spectra. The carboxamido N-H resonance disappears upon coordination to indicate that the 
ligand is coordinated to RuII through the amido protons. The Pyrazine 1H and 13C resonances 
shift downfield due to the electron withdrawing nature of the RuNO center. The downfield shift 
indicates that the pyrazine ring is coordinated through N-1 of each ring. Accordingly, H-1 is the 
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most downfield shifted resonance.  The pyrazyl-ipso 13C  signal shifts downfield 7.0 ppm while 
C-1 shifts only 3.63 ppm.   
For the free ligand, the ethylene protons, H-4 and H-5 produce one signal at 3.53 ppm.  
Upon coordination, the signal splits into two multiplets, one at 3.92 ppm, and the other at 4.09 
ppm.  The differentiation is attributed to the fact that the ethylene backbone is held in a fixed 
position upon coordination.  The two H-5 and two H-4 protons become fixed in axial and 
equatorial positions on the chelate ring with RuII.  Equatorial H-4 and axial H-5 are oriented 
toward the electron withdrawing RuNO, hence resonate at 4.09 ppm while the axial H-5 and 
equatorial H-4 are oriented away for the RuNO moiety and resonate at 3.53 ppm.  The more 
complicated multiplets that appear upon coordination are due to additional geminal coupling. 
The ligand’s 1H NMR spectrum is very similar to that of the pyridine analogue 2.9.  
However, there are the slight differences introduced by the additional nitrogen atom of the 
pyrazine ring.  All of the 1H pyrazyl signals appear slightly more down field for 3.6 than for 2.9.  
The ethylene protons for 3.6 appear at 3.53 ppm while those for 2.9 appear at 3.52 ppm.  Upon 
coordination the ethylene protons exhibit almost exactly the same downfield shifts and the same 
splitting pattern.  The 13C resonances are not differentiated upon coordination for either 2.10 or 
3.7.  The ligands 2.9 and 3.6 have an ethylene 13C resonance at 38.48 and 38.78 ppm, 
respectively.  Upon coordination 13C resonance for each ligand shifts downfield about 13 ppm.    
C-1 for the pyrazine ring is also slightly less affected by coordination than C-1 for the pyridine 
ring.  Infrared data show that donation from the ruthenium center to the π* NO orbitals is less 
efficient for 3.7 (vNO = 1850 cm-1) than for 2.10 ( vNO = 1825 cm-1).   
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     Figure  3.9-N,N′-bis(2-pyridinecarboxamide)-1,2-ethane and RuNO complex 
       
           Table  3.6-1H and 13C NMR Assignments for 3.6 and 3.7 
1H 1 2 3 4 4′ 5 5′ N-H   
3.6 8.71 8.85 9.16 3.53 * 3.53 * 9.09   
3.7 9.41 9.23 9.24 3.92 4.09 4.09 3.92 *   
13C         Pz-ipso C=O 
3.6 143.26 147.41 143.44 38.73 * 38.73 * * 144.73 163.16 
3.7 146.89 149.63 147.07 52.18 * 52.18 * * 151.21 166.26 
  
 
3.4.3 Conclusion 
The 1H and 13C signals for 3.7 are downfield  shifted with respect to those of 3.6. The downfield 
shift is slightly greater than that observed upon coordination of the pyridine analogue, 2.9. NMR 
data do not reveal any major differences due to the pyrazine ring.  However, infrared data 
suggest that back-donation to NOπ* orbitals is less efficient for 3.7 ( v NO = 1850 cm-1) than for 
2.10( v NO = 1825 cm-1).  While v NO for 3.8 is greater than that for 2.10, it is still less than that 
for the benzene derivative, 2.3, for which v NO = 1867 cm-1.  Crystal structure data for 3.6 and 
3.7 are pending and may help explain the difference in v NO for 3.7 and 2.10. 
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3.5 N,N′-BIS(2-PYRAZINECARBOXAMIDE)-1,3-PROPANE 
3.5.1 Materials and Methods 
N,N′-bis(2-pyrazinecarboxamide)-1,3-propane (3.8) was prepared according to a literature 
procedure.68 A solution of 1,3-diaminpropane (d = 0.88 g/mL, 0.593 g, 0.678 mL, 0.008 mol) in 
dry pyridine (~ 4.0 mL) was added to  a solution of pyrazinecarboxylic acid (2.00 g, 0.016 mol), 
in dry pyridine  (~20.0 mL). A white precipitate formed upon addition of 1,3-diaminopropane. 
The reaction mixture was stirred as triphenylphosphite (310.28 g/mol, d = 1.184 g/mL, 4.96 g, 
0.016 mol, 2 equiv) was added by pipette.  The white solid dissolved two hours after stirring for 
two hours at 100 °C.  The reaction was stopped after four hours.  White crystals were collected 
by vacuum filtration after the reaction mixture was to stand for three days at ambient 
temperature.  X-ray quality crystals were obtained after several recrystallizations from ethanol 
and then from water. Yield: 1.18 g, 58 % yield; 1H NMR (300 MHz, DMSO-d6, δ):  9.17 (d, 2H, 
H-3), 9.07 ( t, 2H, N-H(1), N-H(2)), 8.85 (m, 2H, H-2), 3.35 (q, 4H, H-4), 1.77 (m, 2H, H-
5);13C{H} (125 MHz, DMSO-d6, δ): 162.88 (C=O), 147.41(C-1), 144.74 (Pz-ipso), 143.43 (C-3), 
143.25 (C-2), 36.33 (C-4), 29.07 (C-5); ESI-MS M+. = 286. 
 
Chloro-nitrosyl-N,N′-bis(2-pyrazinecarboxamido)-1,3-propane ruthenium(II) (3.9) was 
prepared according to a modified literature procedure.69 Trichloronitrosylruthenium (273.4 
g/mol, 0.478 g, 0.0017 mol) was added to ethanol/water solution (95%, ~40.0 mL, 85.0 °C) of 
N,N′-bis(2-pyrazinecarboxamide)-1,3-propane (286.29 g/mol, 0.500 g, 0.0017 mol).  An 
additional 20.0 mL of the ethanol/water solvent was used to transfer the [Ru(NO)Cl3(H2O)2].  
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Upon addition of [Ru(NO)Cl3(H2O)2] the reaction mixture became orange and a precipitate 
formed.  The reaction mixture was stirred for eleven hours.  The brown/orange precipitate was 
removed by vacuum filtration.  The filtrate volume was reduced under vacuum (rotary 
evaporator) and stored at ambient temperature for crystal formation.  X-ray quality crystals were 
obtained from the filtrate. No yield was obtained.  1H NMR (500 MHz, DMSO-d6,  δ):  9.34 (d, 
4H, H-1, H-3), 9.20 (d, 2H, H-2),   13C{H} (125 MHz, DMSO-d6, δ):  168.04 (C=O), 148.55 (C-
2), 147.12 (Pz-ipso), 146.64 (C-1), 144.25 (C-3), 46.07 (C-4), 30.14 (C-5).   
3.5.2 Results and Discussion 
Figure 3.10 shows the labeling schemes for 3.8 and 3.9. The corresponding 1H and 13C NMR 
data are in Table 3.7.  All resonances were assigned based upon 2-D NMR analysis. The HH 
COSY spectrum of 3.8 is shown in Figure 3.11.  The broad triplet at 9.07 ppm is assigned to the 
N-H protons; the N-H protons exhibit a correlation with H-4.  H-2 and H-1 correlate with each 
other but show a weak long range correlation with H-3 as well.  13C assignments were made 
based upon HMQC and HMBC spectra.  
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Figure  3.10-N,N′-bis(2-pyridinecarboxamide)-1,3-propane  and RuNO complex  
Table  3.7-1H and 13C NMR Assignments for 3.8 and 3.9 
1H 1 2 3 4 4′ 5 5′ N-H   
3.8 8.71 8.85 9.17 3.35 * 1.77 * 9.07   
3.9 9.34 9.34 9.20 3.74 3.58 1.79 2.09 *   
13C         Pz-ipso C=O 
3.8 147.41 143.25 143.43 36.33 * 29.07 * * 144.77 162.88 
3.9 146.64 148.55 144.25 46.07 * 30.14 * * 147.12 168.04 
 
 
Figure  3.11- HH COSY spectrum of 3.8 
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All of the 1H NMR signals shift downfield upon coordination to the RuNO center.  The 
largest downfield shift occurs for H-1 which is adjacent to the coordinating nitrogen of the 
pyrazine group.  The H-4 triplet splits into two multiplets that resonate downfield from the 
original signal at 3.35 ppm.  One H-4 resonance appears at 3.58 ppm, the other at 3.74 ppm.  The 
resonance at 3.58 ppm is assigned to the equatorial protons which are oriented more toward the 
RuNO side of the chelate ring than are the axial protons. The crystal structure in Figure 3.12 can 
be viewed for clarification,  but be aware that the numbering system is different for the crystal 
structure.  The H-5 multiplet is also split into two multiplets upon coordination.  One multiplet, 
assigned to the equatorial proton, shifts very little, from 1.77 ppm to 1.79 ppm; the other 
multiplet, assigned to the axial proton which is oriented toward the RuNO moiety, shifts 1.07 
ppm downfield to 2.09 ppm.  The 13C resonance for C-4, coordinating nitrogen atoms shifts 
downfield 9.74 ppm.   The 13C resonance for C-5 shifts only 1.07 ppm because it is one carbon 
atom removed from the coordinating nitrogen atoms.  C-1, adjacent to the coordinating pyrazine 
nitrogen exhibits a very slight upfield shift compared to the free ligand while its corresponding 
proton shifts downfield.  The carbonyl and pyrazyl-ipso carbons shift downfield 2.35 and 5.16 
ppm, respectively. 
Crystal intensity and collection data can be seen in Table 3.8.  The crystal structure of 3.8 
can be seen in Figure 3.12.  Table 3.9 presents some selected bond distances and angles for 3.8.  
The X-ray structure for 3.9 is in Figure 3.13; selected bond distances and angles are in Table 
3.10.   The most noticeable changes are in the bond angles.   
The  N(3)-C(3)-C(4) angle is 2° larger than the corresponding angle across from it, N(2)-
C(1)-C(2) (121.0(2)°).  In 3.8 those angles almost the same at 122.4(4)° and 121.9(4)°, 
respectively. Since N(1) and N(4) of the complex are bound and C(4) is bound to the carbonyl 
 89 
group, the N(3)-C(3)-C(4) angle might distort to compensate for chelation. A similar distortion 
occurs in the other pyrazine ring on 3.9.  Angles N(4)-C(5)-C(4) and N(5)-C(9)-C(10) as well as 
N(2)-C(4)-C(5) and N(6)-C(10)-C(6) are 3-4° smaller than the corresponding angles of 3.8.  
These angles are centered about the carbonyl and the ipso carbons.  
The N(4)-C(6)-C(7) angle of 3.9 is the same as that of the ligand, 114°; however the 
corresponding angle of 3.9, N(5)-C(8)-C(7) is 2° smaller.  This difference and the increase in the 
C(6)-C(7)-C(8) angle upon coordination are attributed to the bite angle of the propanediamide 
and the fact that the one pyrazine ring has to tilt out of the equatorial plane to avoid in interaction 
between H-1 and H-13.  The Ru-NO angle, 177.89 is typical of linear {RuNO}6 complexes.  The 
N(1)-Ru- N(5) and N(1)-Ru-N(4) angles are about the same at 95.71° and 94.55°.  However, the 
angles between the nitrosyl nitrogen, ruthenium and the pyrazyl nitrogen atoms, N(1)-Ru-N(6) 
and N(1)-Ru-N(2), differ by a little over 3° as a result of the N(6) pyrazyl group’s out of plane  
tilt. The equatorial angles that include a pyrazyl nitrogen and a carboxamide nitrogen, N(2)-Ru-
N(4) and N(6)-Ru-N(5) are both close to 78°.  The N(4)-Ru-N(5) angle which includes both 
carboxamido nitrogen atoms at 95.76° is  11.1° smaller than the N(2)-Ru-N(6) angle that 
includes the pyrazyl nitrogen atoms. 
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Table  3.8-Crystal data and refinements for 3.8 and 3.9 
 
 
 3.8 3.9 
Chemical Formula C13H18N6O4 C13H12ClN7O3Ru 
Formula Weight 322.33 450.82 
Temperature (K) 150(2) 295(2) 
Wavelength (Å) 0.71073 0.71073 
Crystal system Monoclinic Triclinic 
Space group P-2(1) P-1 
a (Å) 5.2057(2) 7.4306(6) 
b (Å) 19.060(7) 10.3562(9) 
c (Å) 7.930(3) 11.2674(1) 
α (°) 90 67.1930(1) 
β (°) 106.079(7) 84.375(2) 
γ (°) 90 79.042(2) 
Volume (Å3) 756.0(5) 784.41(1) 
Z 2 2 
Density (calculated) Mg/m3 1.416 1.909 
Absorption Coefficient (mm-1) 0.108 1.201 
F(000) 340 448 
Crystal Size (mm3) ? x ? x ? 0.29 x 0.21 x 0.18 
θ range for data collection (°) 2.14 to 27.49 1.96 to 32.46 
Index Ranges -6 ≤ h ≤ 6 -11 ≤ h ≤ 11 
 -24 ≤ k ≤ 24 -15 ≤ k ≤ 15 
 -10≤ l ≤ 10 -16 ≤ l ≤ 16 
Reflections collected 7374 10418 
Independent reflections 1789 [R(int) = 0.0735] 5400 [R(int) = 0.0174] 
Completeness 100.0 % (θ =27.49°) 95.4 % (θ =32.46) 
Data / restraints / parameters 1789/ 0 / 232 5400 / 0 / 226 
Max. and min. transmissions 0.9856 and 0.9733 0.8129 and 0.7221 
Refinement Method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Goodness-of-fit on F2 0.828 1.187 
Final R indices[I > 2σ (I)] R1 = 0.0488, wR2 = 0.1059 R1 = 0.0312, wR2 = 0.0780 
R indices (all data) R1 = 0.0922, wR2 = 0.1234 R1 =0.0348, wR2 = 0.0798 
Largest diff. peak and hole (e  Å3) 0.218 and -0.168 0.821 and  -0.323 
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Figure  3.12-X-ray structure of 3.8 
 
                           Table  3.9- Selected bond distances (Å) and angles (°) for 3.8 
 
O(1)-C(5) 1.226(5) C(10)-C(11) 1.384(6) 
O(2)-C(9) 1.232(5) C(3)-C(4) 1.394(6) 
N(4)-C(8) 1.442(6) N(5)-C(10) 1.339(5) 
N(3)-C(6) 1.454(5) N(6)-C(11)  1.338(6) 
C(7)-C(8) 1.527(6) N(2)-C(3) 1.331(6) 
C(6)-C(7) 1.521(6) N(6)-C(12) 1.335(5) 
C(4)-C(5) 1.496(6) N(2)-C(2) 1.318(6) 
C(9)-C(10) 1.506(6) C(12)-C(13) 1.386(6) 
N(4)-C(9) 1.333(5) C(1)-C(2) 1.371 
N(3)-C(5) 1.325(5) N(5)-C(13) 1.336(6) 
    
N(4)-C(8)-C(7) 114.5(4) N(6)-C(12)-C(13) 122.3(4) 
N(3)-C(6)-C(7) 115.8(3) N(2)-C(2)-C(1) 122.4(4) 
C(6)-C(7)-C(8) 108.4(3) N(5)-C(13)-C(12) 121.9(4) 
N(3)-C(5)-C(4) 116.3(4) N(1)-C(1)-C(2) 122.5(4) 
N(4)-C(9)-C(10) 116.0(4) C(1)-N(1)-C(4) 115.5(3) 
N(5)-C(10)-C(11) 121.7(4) C(13)-N(5)-C(10) 116.1(4) 
N(1)-C(4)-C(3) 121.5(4) N(5)-C(10)-C(9) 119.2(4) 
N(6)-C(11)-C(10) 121.9(4) N(1)-C(4)-C(5) 119.4(4) 
N(2)-C(3)-C(4) 121.9(4)   
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 Figure  3.13-X-ray structure of  3.9 
Table  3.10-Selected bond distances (Å) and angles (°) for 3.9 
 O(1)-N(1) 1.132(2) O(2)-C(5) 1.235(2) 
Ru-N(1) 1.7452(2) O(3)-C(9) 1.231(2) 
Ru-Cl 2.3439(6) N(4)-C(5) 1.324(3) 
Ru-N(2) 2.1248(2) N(5)-C(9) 1.335(3) 
Ru-N(6) 2.1415(2) N(4)-C(6) 1.461(3) 
Ru-N(4) 2.0143(2) N(5)-C(8) 1.468(2) 
Ru-N(5) 2.0201(2) C(6)-C(7) 1.502(4) 
C(1)-N(2) 1.334(3) C(7)-C(8) 1.515(3) 
C(1)-C(2) 1.376(3) C(3)-C(4) 1.381(3) 
C(2)-N(3) 1.327(3) N(2)-C(4) 1.346(2) 
N(3)-C(3) 1.332(3) C(4)-C(5) 1.498(3) 
O(1)-N(1)-Ru 177.89(2) C(9)-C(10) 1.496(3) 
N(1)-Ru-Cl 176.96(5) N(5)-Ru-N(6) 78.02(6) 
N(1)-Ru-N(2) 94.48(7) N(5)-Ru-N(2) 168.61(7) 
N(1)-Ru-N(6) 91.19(7) N(4)-Ru-N(6) 171.95(6) 
N(1)-Ru-N(5) 95.71(7) N(4)-C(6)-C(7) 114.34(2) 
N(1)-Ru-N(4) 94.55(7) C(6)-C(7)-C(8) 115.0(2) 
N(4)-Ru-N(5) 95.76(7) C(8)-N(5)-Ru 123.08(1) 
N(2)-Ru-N(6) 106.86(6) C(6)-N(4)-Ru 123.21(1) 
N(4)-Ru-N(2) 78.35(7) N(5)-C(9)-C(10) 112.43(2) 
N(2)-C(4)-C(5) 116.71(2) N(4)-C(5)-C(4) 112.74(2) 
N(6)-C(10)-C(9) 116.69(2) N(5)-C(8)-C(7) 112.15(2) 
C(1)-N(2)-C(4) 117.33(2) C(13)-N(6)-C(10) 117.29(2) 
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3.5.3 Conclusion 
The N,N′-bis(2-pyrazinecarboxamide)-1,3-propane ligand (3.8) was prepared and characterized 
by 2D NMR methods and by X-ray crystallography.   The crystal structure of Chloro-nitrosyl-
N,N′-bis(2-pyrazinecarboxamido)-1,3-propane ruthenium(II) (3.9) reveals a linear Ru-N-O bond 
of 177.89(15)° and an N-O bond distance of  1.132(2) Å. These values are similar to those for 
2.12 which are 177.5(7) and 1.143(8) Å, respectively. There are some variations in the bite 
angles between 3.10 and 2.12.  For 3.9 N(4)-Ru-N(5) is 95.76(7)° is slightly larger than the 
corresponding angle for 2.12 at  95.4(3)°.  The N(2)-Ru-N(6) angle for 3.9 is 106.86(6)° is 
slightly less than that for 2.12 which is 107.3(2)°.  The Namide Ru-Npy/pz bond angles are all about 
the same at ~ 78°. The Ru-N pyrazine bond distances are about the same for 2.12 and 3.9, 
however, the Ru-N carboxamido bonds are slightly shorter for 3.10 than for 2.12. There are other 
slight differences in the NNO-Ru-Nequat. angles between the 3.9 and 2.12.  These variations are 
attributed to the degree to which the pyrazine or pyridine arms have to tilt out of plane to avoid 
an interaction between the pyridyl arms. Infrared data have not been obtained as of this report 
but will indicate the extent of back-donation to the NOπ* orbitals. The shorter NO bond distance 
for 3.9 suggests that v NO for 3.9 will be greater (back-donation will be less) for 3.9 than for 2.12.  
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3.6 N,N′-BIS(2-PYRAZINECARBOXAMIDE)-1,4-PIPERAZINE 
3.6.1 Materials and Methods 
N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine (3.10) was prepared according to a literature 
procedure.68  Pyrazinecarboxylic acid (10.0 g, 0.0805 mol) was dissolved in dry pyridine (~40.0 
mL).  To the picolinic acid solution was added piperazine (3.47 g,  0.040 mol) and triphenyl 
phosphite (d = 1.184 g/mL, 21.0 mL, 0.0805 mol).  The reaction mixture was stirred at 100 °C 
for four hours.  After three days at room temperature the reaction mixture began to yield crystals.  
Recrystallization form DMSO produced X-ray quality crystals. 1H NMR (500 MHz, DMSO-d6,  
δ):  8.87 (d, 2H, H-3), 8.74 (d, 2H, H-2), 8.67 (d, 2H, H-1), 3.79 (s, 2H, H-6), 3.70 (m, 2H, H-7), 
3.60 (m, 2H,  H-4), 3.99 (s, 2H, H-5);   13C{H} (125 MHz, DMSO-d6, δ): 164.86 (C=O),  148.87 
(Pz-ipso), 145.53 (C-2), 144.53 (C-3), 143.05 (C-1), 46.69 (C-5), 46.07 (C-4), 41.97 (C-7), 
41.37(C-6); ESI-MS M+. = 298.11 
 
N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine reaction with [Ru(NO)Cl3(H2O)2] The 
reaction between N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine and [Ru(NO)Cl3(H2O)2] was 
carried out according to a modified literature procedure.69 Trichloronitrosylruthenium (0.594 g, 
0.0021 mol) was added to ethanol/water solution (95%, ~20.0 mL, 85.0 °C) of N,N′-bis(2-
pyrazinecarboxamide)-1,4-piperazine (0.648 g, 0.0021 mol).  And additional twenty milliliters of 
95% ethanol/water was used to completely transfer the [Ru(NO)Cl3(H2O)2].  The reaction 
mixture was stirred at 85 °C for ten hours.  A brown precipitate was removed from the reaction 
mixture via vacuum filtration.  The filtrate volume was reduced under vacuum and stored at 
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ambient temperature for crystal formation.  A precipitate was removed from the filtrate after 
several days. The precipitate was rinsed several times and was determined to be mostly the free 
ligand from 1H NMR spectroscopic analysis.  The orange ethanol wash was allowed to evaporate 
slowly at room temperature.  After several days an orange precipitate formed.  Preliminary NMR 
results indicate formation of a new species.  The NMR spectrum of the new species and of the 
free ligand can be viewed in Figure 3.16. 
3.6.2 Results and Discussion 
The ligand N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine (3.10) was prepared as described 
and characterized by 1H and 13C NMR spectroscopy. 1H and 13C  assignments were made based 
upon HH COSY, HMBC and HMQC spectra.  The identity of the ligand was also confirmed by 
X-ray and mass spectral analysis.  The labeling scheme for the NMR assignments is shown in 
Figure 3.14.  The chemical shift values are listed in Table 3.11.  The signals for the two pyrazine 
moieties are similar to those for other pyrazine compounds described in this section.    There are 
separate signals for each carbon and each set of nitrogen atoms for the piperazine ring.  The 1H 
NMR spectrum is shown in Figure 3.16.   
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Figure  3.14-N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine 
Table  3.11-1H and 13C NMR Data for N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine  
 
1H 1 2 3 4 5 6 7   
 8.87 8.74 8.67 3.60 3.99 3.79 3.70   
          
13C        Pz-ipso C=O 
 143.05 145.53 144.53 46.07 46.69 41.37 41.97 148.87 164.86 
          
 
 
 
        
 
 
Crystal intensity and collection data are reported in Table 3.12.  The X-ray crystal structure of 
3.10 is shown in Figure 3.15.  Selected bond distances and angles can be seen in Table 3.13.   
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Table  3.12-Crystal data and refinements for 3.10 
 
3.10   
Chemical Formula C14H14N6O2
Formula Weight 298.31  
Temperature (K) 295(2) 
Wavelength (Å) 0.71073 
 Crystal system Monoclinic 
Space group P 21/n 
a (Å)  5.8383(4) 
b (Å) 18.2912(1) 
c (Å) 6.8413(4)  90 α (°) 
109.2710(1) β (°) 
 90 γ (°) 
Volume (Å3) 689.64(7) 
 Z 2 
Density (calculated) Mg/m3 1.437 
Absorption Coefficient (mm-1) 0.102  F(000) 312 
Crystal Size (mm3) 0.24 x 0.22 x 0.12 
 2.23 to 32.54 θ range for data collection (°) 
Index Ranges -8 ≤ h ≤ 8 
  -27 ≤ k ≤ 27 
 -10 ≤ l ≤ 10 
Reflections collected 8985  Independent reflections 2450 [R(int) = 0.0241] 
Completeness 97.8 % (θ =32.54°) 
 Data / restraints / parameters 2450/ 0 / 128 
Max. and min. transmissions 0.9560 and 0.9464 
Full-matrix least-squares on F2Refinement Method  
Goodness-of-fit on F2 1.414 
R1 = 0.0757, wR2 = 0.1960 Final R indices[I > 2σ (I)]  R indices (all data) R1 = 0.0890, wR2 = 0.2049 
Largest diff. peak and hole (e  Å3) 0.408 and -0.267 
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                   Figure  3.15-X-ray structure of N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine 
 
Table  3.13 Selected bond distances (Å) and angles (°) for 3.10 
 O-C(5) 1.2195(2) C(5)-N(3)-C(6) 126.52(1) 
N(1)-C(1) 1.3353(2) C(5)-N(3)-C(7) 119.45(1) 
 N(1)-C(4) 1.3364(2) C(6)-N(3)-C(7) 113.71(1) 
N(2)-C(2) 1.331(2) O-C(5)-N(3) 123.21(1) 
N(2)-C(3) 1.330(2) O-C(5)-C(4) 117.87(1)  
N(3)-C(5) 1.3434(2) N(3)-C(5)-C(4) 118.91(1) 
N(3)-C(6) 1.4594(2) N(3)-C(6)-C(7A) 110.47(1) 
 N(3)-C(7) 1.4628(2) N(3)-C(7)-C(6A) 109.75(1) 
C(6)-C(7A) 1.499(3) N(3)-C(6)-H(6A) 110.8(1) 
 C(7)-C(6A) 1.499(3) N(3)-C(6)-H(6B) 106.0(1) 
C(6)-H(6A) 0.979(9) C(7A)-C(6)-H(6A) 106.7(1) 
C(6)-H(6B) 1.05(2) C(7A)-C(6)-H(6B) 105.3(1)  
C(7)-H(7A) 1.01(3) N(3)-C(7)-H(7A) 107.0(2) 
C(7)-H(7B) 0.95(3) N(3)-C(7)-H(7B) 105.8(2)  
 
 
 
The reaction between 3.10 and [Ru(NO)Cl3(H2O)2] produced an orange precipitate from the 
filtrate.  The NMR spectrum of the solid indicates the presence of some free ligand along with 
what appears to be one new product.  The NMR spectra of the product and the free ligand can be 
seen Figure 3.16.  
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                                   a.                                                                                                       b. 
Figure  3.16- a. 1H NMR Spectrum of aryl region of 3.15  b. Reaction mixture 
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3.6.3 Conclusion 
The ligand N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine was synthesized and characterized 
by NMR spectroscopy and X-ray crystallography.  Preliminary results from a reaction between 
3.10 and [Ru(NO)Cl3(H2O)2] suggest that one new species has been isolated from the reaction 
mixture.  Complete analysis of the new complex awaits separation of the new complex from the 
ligand. 
3.7 GENERAL CONCLUSION 
The ligands N,N′-bis(2-pyrazinecarboxamide)-1,2-benzene, N,N′-bis(2-pyrazinecarboxamide)-2,3- 
diaminopyridine, N,N′-bis(2-pyrazinecarboxamide)-3,4-diaminopyridine, N,N′-bis(2-
pyrazinecarboxamide)-1,2-ethane, N,N′-bis(2-pyrazinecarboxamide)-1,3-propane, and 
N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine were prepared and characterized by 13C and 1H 
NMR spectroscopy and/or X-ray crystallography.  Although some of the complexes remain to be 
isolated, it seems that all pyrazine derivatives react with Ru(NO)Cl3(H2O)2] to form RuNO 
complexes.  The complexes that have been prepared exhibit binding modes similar to the 
pyridine analogues.   
The N,N′-bis(2-pyrazinecarboxamide)-1,2-benzene ligand has been characterized by X-
ray crystallography.  The reaction between the ligand and [Ru(NO)Cl3(H2O)2] yielded a complex 
similar to the prydine analogue but with expected variations in NMR data attributed to 
differences between the pyridine and pyrazine rings.  Neither the crystal structure nor the 
infrared data for the complex are available at this time.   
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N,N′-bis(2-pyrazinecarboxamide)-2,3-diaminopyridine ligand was characterized by 1H 
and 13C NMR spectrosopy.  Assignments were made based upon HH COSY, HMQC and HMBC 
data.  No product from the reaction between [Ru(NO)Cl3(H2O)2]  has been isolated at this time.  
However, preliminary NMR data suggest the formation of more than one product, one of which 
might exhibit a coordination mode similar to the pyridine analogue which binds through one 
pyridine arm and one carbonyl oxygen atom. 
The N,N′-bis(2-pyrazinecarboxamide)-3,4-diaminopyridine ligand was characterized by 
1H NMR spectroscopy. Assignment of the signals awaits 2D analysis.  However, at least one 
compound has been isolated from the reaction between the ligand and [Ru(NO)Cl3(H2O)2].  The 
disappearance of the N-H signals and the downfield shift of all signals in the 300 MHz NMR 
spectrum of the product indicates that the ligand coordinates through the carboxamido and 
pyrazine arms.  This promising result confirms that tetradentate coordination is possible with 
theses 2,3- and 3,4-diaminopyridine derivatives.  It will be interesting to see which coordination 
mode is favored by each and how the RuNO moiety is affected. 
The bis(2-pyrazinecarboxamide)-1,2-ethane ligand has been characterized by 2D NMR 
analysis and compared to pyridine analogue.  Differences due to the pyrazine ring were noted.  
The RuNO complex with the ligand was also characterized by 2D analysis and shows features 
similar to the complex with the pyridine analogue. At 1850 cm-1. v NO for the pyrazine complex 
is higher than that for the pyridine analogue for which v NO =1825 cm-1.  No other conclusions 
can be drawn until the crystal structure is obtained.  
The N,N′-bis(2-pyrazinecarboxamide)-1,3-propane ligand (3.9) and chloro-nitrosyl-N,N′-
bis(2-pyrazinecarboxamido)-1,3-propane ruthenium(II) (3.10) complex were prepared and 
characterized by 2D NMR analysis and X-ray crystallography. The RuNO complex exhibits a 
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linear nitrosyl group with and O(1)-N(1)-Ru angle of 177.89(15)° and N-O bond length of 
1.132(2) Å.  In comparison, the pyridine derivative exhibits a linear Ru-N-O angle of 177.5(7)° 
and an N-O bond distance of 1.143(8).  Although infrared data have not been acquired, the 
longer N-O bond observed for 2.12 suggests that the stretching frequency for 3.10 should be 
greater than for 2.12.  That 3.7 exhibits v NO that is greater than that of its pyridine analogue also 
suggests that a lower v NO can be expected for 3.9. 
The N,N′-bis(2-pyrazinecarboxamide)-1,4-piperazine ligand (3.10) was prepared and 
characterized by NMR spectroscopy and X-ray crystallography. 1H NMR data for the reaction 
between the ligand and [Ru(NO)Cl3(H2O)2]suggest formation of at least one new product.  This 
ligand like its pyridine analogue and the alkyl analogues should provide useful information about 
the magnetic anisotropy about the Ru-N-O moiety.   
In summary, six bis-pyrazine bis-carboxamido and six bis-pyridine bis-carboxamido 
ligands were prepared. The ligands were designed with minor variations to adjust the ligand 
environment with the aim of producing ruthenium nitrosyl complexes that can withstand a 
physiological environment, lose NO by photolysis then stabilize the remaining RuIII complex.  
Eventually photolysis data can be correlated with the changes in the ligand environment to arrive 
at the best ligand set for photolysis of NO. The change from pyridine to pyrazine, not only helps 
understand  how changes in the ligand environment influence the RuNO moiety, but also  
introduces the possibility of coordination to another metal centers through the uncoordinated 
pyrazine nitrogen atom. Recently, pyrazine bridged ruthenium nitrosyl complexes have been 
shown to release NO under visible light.80  The ligands with a 2,3- and 3,4-diaminopyridine 
backbone also introduce some promising additional coordination sites.  
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APPENDIX 
REVIEW OF PROFESSOR SHEPHERD’S RESEARCH 
Much of the Professor Shepherd’s early work with ruthenium complexes, N-heterocyclic ligands 
and other biologically relevant ligands provided a foundation for the current applications to 
biochemistry.  Therefore, a review of those investigations and others is provided  in this 
appendix. 
Under the direction of Professor Henry Taube, Professor Shepherd investigated the 
reaction between aquopentammineruthenium(II) ([RuII(NH3)5(H2O)]2+) and nitrogen-containing 
heterocyclic ligands including pyridine, pyrazine and imidazole, among others.81 While a 
graduate student, Professor Shepherd27,82,83 discovered that, although imidazoles are usually N-
bound, they can coordinate through C-2 to [RuII(NH3)5(H2O)]2+ as imidazolium ylide. An 
imidazolium ylide is shown in Figure A.1.  The ruthenium bound imidazolium ylide is shown in                 
NHNH
R R
+N(1)
C(2)
N(3)
C(4)C(5)
 
Figure A.1-Imidazloium Ylide 
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Scheme A.1-C-Bound ruthemium imidazole complex 
 
The fact that imidazoles can bind through C-2, as well as through the pyridine nitrogen, 
might have important biological implications. Histidine (Figure A.2) a derivative of imidazole, 
binds to the metal ion centers in many metalloenzymes and heme proteins. Many84-86 have 
pursued the possibility that linkage isomerization between N-3 and C-2 of histidine could trigger 
physiological functions. Today imidazolium ylides are used to improve catalyst performance, 
stability and recyclability and to  provide sites for functional group introduction16,87-89  
H2N CH C
CH2
OH
O
N
NH  
Figure A.2- Histidine 
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Investigations into the interaction of imidazoles, substituted imidazoles90 and histidine 
with pentacyanoiron(II) and pentacyanoiron(III) moieties were initiated.91,92 Electrochemical 
studies of [(CN)5FeL]2-/3- and [(NH3)5RuL]3+/2+ imidazole and pyrazole complexes illustrated that 
a ligand’s  π-acceptor ability has a stronger effect on reduction potential than does the ligand’s π-
donating character.93    The influence of metal centers on the pKa of the pyrrole hydrogen of 
imidazole complexes,94,95 and of pyrazole complexes was also studied96.   
The role of imidazoles in physiological processes was examined by analyzing the ligand 
to metal charge transfer transitions (LMCT) of low-spin d5 FeIII and RuIII pyrazole/imidazole and 
pyrazolato/imidazolato complexes.97,98 The solvatochromism of the LMCT transition of 
[Fe(CN)5]2+ complexes99,100  and the 1H and 13C NMR spectra of methylimidazole cobalt 
complexes.  [Co(NH3)5(Me-Im)]3+ (Me-Im = methylimidazole) was prepared to mimic histidyl 
moieties in ZnII enzymes in which the histidyl side chain can be either adjacent to or remote from 
the coordination site. [Co(NH3)5(Me-Im)]3+ complexes exhibiting adjacent and remote binding 
(Figures A.3  and  A.4) were characterized by NMR spectroscopy.  An X-ray crystal structure of 
the remote isomer (Figure A.5) allowed unambiguous chemical shift assignments.  The NMR 
data illustrated that generalizations from other low-spin d6 complexes with nitrogen heterocyles 
cannot be applied to tautomeric imidazoles.101,102  NMR studies that followed the  
[Co(NH3)5(Me-Im)]3+ experiments showed that the influence of temperature induced 
paramagnetic (TIP) on  1H NMR chemical shift values for η-2 coordinated N-heterocycles is 
minimal in comparison to the σ withdrawing effect of the metal center and rehybridization upon 
coordination.96   
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Figure A.3-Adjacent Isomer of (4-methylimidazole)pentaamminecobalt(III) 
Reprinted with permission from J. Am. Chem. Soc., 1983 22 2693.   Copyright 1983 American Chemical 
Society.  
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Figure A.4-Remote Isomer of (4-methylimidazole)pentamminecobalt(III) 
Reprinted with permission from J. Am. Chem. Soc., 1983 22 2693.   Copyright 1983 American Chemical 
Society.  
 
Figure A.5-Structure of the remote isomer of [Co(NH3)5(4-MeIm)]3+
Reprinted with permission from J. Am. Chem. Soc., 1986, 25, 3157.   Copyright 1986 American Chemical 
Society.  
 
Observations from the imidazole work helped elucidate the processes involved in 
immobilized metal affinity chromatography (IMAC). IMAC is a method developed by Porath 
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and coworkers103,104 to purify proteins.  In IMAC, a chelated metal ion which is attached to a 
solid support and interacts with proteins. Proteins that have a higher affinity for the chelated 
metal ion elute more slowly from the column than proteins that have lesser affinity for it.  Until 
1999 there was much debate about the nature of the coordination that occurs between a protein 
and the IMAC metal center. In collaboration with Richard Pasquinelli, Mohammad Ataai, and 
Richard Koepsel, definitive evidence of a three donor attachment was presented. Interactions 
between the six-mer peptide gly-his-pro-his-his-gly (GHPHHG) and CuII and PdII N-
methyliminodiacetate complexes were used to model IMAC interactions. The model peptide tails 
were shown to attach at the first, third and fourth amino acid donors in order to approach the 90° 
bond angle favored for square planar coordination.  The imidazole donors of histidine coordinate  
such that the three methylene linkers are adjacent, remote and adjacent to the coordinating 
nitrogen for the model GHPHHG.105,106  Comprehensive NMR analysis of the model system 
helped identify another tag, his-pro-his-his-gly-gly (HPHHGG), that has affinity for purification 
from ZnII iminodiacetate columns at pH 6.5-6.107  
 A molecular modeling study compared the energy-minimized structures of [Pd(mida)] 
complexes of peptide sequences used in IMAC chromatography. The small differences in the 
calculated energies of H6, GHPHHG and ser-pro-his-his-gly-gly (SPHHGG) correlate with 
elution order. The most relaxed sequence, imH6, is bound most strongly hence elutes most 
slowly from the column. The most relaxed ligand exhibits the strongest MII-N because it is the 
least strained. The elution order does not have to be the same as the minimum energy order but it 
does suggest that the two values are based on similar factors.108 Two related reviews were 
published in 2003.  One review was on general chromatographic methods;109 the other was on 
chromatographic and electrophoretic methods in the separation or transition metals.110 
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In 1983 the first series of low-spin FeIII complexes, [(CN)5FeIII(imidazoles)]2- and 
[(CN)5FeIII(pyrazoles)]2-, to exhibit the maximum 2.54 mm/s quadrupole splitting as predicted in  
1967 by Golding111 was reported. Two years later, in collaboration with Professor Sanford 
Asher, resonance Raman excitation profiles were used to distinguish between the π orbitals 
involved in the ligand to metal charge-transfer transitions for [(CN)5FeIII(imidazole)]2− and 
[(NH3)RuIII(imidazole)]3+.112  Evidence was presented for the proton-promoted chelate-ring 
opening of copper(II) polyamine complexes through the 3-centered electrophilic attack by H3O+ 
on the metal nitrogen bonds. This direct ligand substitution pathway was proposed initially by 
Wilkins as an alternative to simple dissociative cleavage.113 A computational model based upon  
the infrared analysis of polyamine complexes with copper(II), including bis(ethylenediamine) 
and bis(trimethylenediamine), among others, was devised to help elucidate controversial 
vibrational assignments.114,115  A water soluble porphyrin complex [Ru(TPPS)CO]4−  (TPPS = 
tetraphenylporphyrinato) was prepared and shown to catalyze the water gas shift reaction without 
cluster- and hydride-forming side reactions. Such side reactions reduce the activity of 
mononuclear catalysts, [Fe(CO)5], [Mo(CO)6], [W(CO)6] and the trinuclear catalyst 
[Ru3(CO)12].116  
 In the late 1980’s experiments were initiated to dearomatize N-heterocycles. 
Concurrent with this work, the Taube group had dearomatized lutidine, pyrrole and N-
methylpyrrole with [(NH3)5Os]2+.  An alternative approach was to use 
ruthenium(II)polyaminocarboxylates ([RuII(pac)]).  [RuII(pac)] complexes are much less toxic 
than the OsII reagents, thus could have medicinal applications. Earlier it was shown that the 
stability of [Ru(NH3)5(pyrazine)]2+ was due more to dπ-pπ backbonding than to pyrazine’s 
basicity.117,118  To estimate the extent of charge transfer from RuII into π-acceptor orbitals, a π-
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acceptor scale was developed based upon photoelectron spectroscopy (PES). The π-acceptor 
order CH3pz+ > CO > dmad (dimethylacetylenedicarboxylate) > pz > CH3CN > py, agrees with 
literature estimates based upon titration data and UV-vis data.119  Later a method for measuring 
the  π-donor capacity of RuII centers based upon the MLCT spectra of pyrazine and 4,4′-
bipyridine was published.120   
The similarities between [W0(CO)5L] where L = pyridine, pyrazines, pyrimidines and 
pyridazine and analogous [Ru(NH3)5L]2+ prompted an investigation for an isomerization pathway 
from N-1 to N-4 on the pyrazine ring for [W(CO)5]. The solvents acetone and diglyme prohibited 
observation of the required η2 intermediates by 1H NMR studies.   If the η2 intermediates do exist 
they probably cannot survive long enough to be detected due to solvent displacement.121 It was 
believed that a shorter path for migration might lead to the fluxionality observed for pyridazines.  
Therefore studies similar to the pyrazine studies were completed with pryimidine and 1,3,5-
triazine and M(CO)5 (M = W, Mo, Cr).  Even with a two-bond path the barrier for migration was 
too large for migration to be observed.122  
Since the π-base behavior of [(NH3)5Ru]2+, and of [(NH3)4Os]2+,  toward π-acids such as 
pyridines and pyrazines had been well studied,  this research was extended to include the affinity 
of [(NH3)5Ru]2+ toward π-acids such as olefins, acetylenes and CO, which are of more interest to 
organic chemists.  NMR data revealed that π donation from the metal center into olefinic π* 
orbitals, can affect atoms that are two and three bonds away from the coordination site.123,124  
The effect of [(NH3)5Ru]2+ on the bend-back angles of dmad were examined by X-ray diffraction 
and compared to other [(NH3)5Ru]2+ complexes with π-acceptor ligands.125   
The experiments with [(NH3)5Ru]2+, [(NH3)5Os]2+, and RuII polyaminocarboxylates were 
extended to test the generality of the long range effect π-donation to π–acceptor ligands. Styrene 
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complexes of [(NH3)5Ru]2+, [(NH3)5Os]2+ and [RuII(hedta)]− were prepared and characterized by 
NMR spectroscopy.  The styrene complexes exhibited the same changes in 1H and 13C chemical 
shifts as do linear olefins upon coordination. Another important conclusion from the styrene 
experiments is that disruption of aromaticity only occurs in the absence of alternate metal 
binding sites.  For example, [(NH3)5Ru]2+  and  [(NH3)5Os]2+ will only bind to the exo-vinylic 
donor of styrene.126   
Since [(NH3)5Ru]2+/3+ and [(NH3)5Os]2+/3+ were known to bind to purine (Figure A.6) and 
pyrimidine (Figure A.7) bases in DNA and RNA the possibility that these nucleobases might 
also exhibit some dearomatizing π- bonding was investigated.  Given from the styrene studies 
that no olefin-like binding will occur if alternate binding sites are available, 1,3-dimethyl uracil, 
(Figure A-8) in which the N-1 and N-3 ring locations are blocked with methyl groups, was 
selected as substrate.  NMR and electrochemical studies indicated that coordination by 1,3-
dimethyl uracil with [(NH3)5Ru]2+ and with [(NH3)5Os]2+ occurs  through the C-5 and C-6 olefin 
bond.127   
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                                                   Figure A.6-Purine 
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                                                            Figure A.7-Pyrimidine 
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Figure A.8-1,3-dimethyluracil 
 
Since metal complex binding to DNA and RNA nucleobases is pertinent to heavy metal 
labeling of DNA and the development of chemotherapeutics, the 1,3-dimethyl uracil study was 
followed with an investigation of methyl derivatives of uridine (Figure A.15) cytosine (Figure 
A.9) and cytidine (Figure A.10). Only C-5 C-6 olefinic coordination is observed for 
[RuII(hedta)]- complexes   with 1,3-dimethyl uracil, (Figure A.8) uridine,  3-methyluridine, 
cytidine, and 3-methyl cytidine.   The rehydbridization that accompanies η2 coordination disrupts 
aromaticity and suggests that metallation of cytidine or uridine would likely be mutagenic during 
DNA replication because dearomatization would alter the ability of cytidine or uridine to match 
with guanosine and adenosine.  
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Figure A.9-Cytosine 
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Figure A.10-Cytidine 
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Figure A.11-Thymidine 
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  Observation of C-5 and C-6 η2 coordination to uridine by [Ru(hedta)]-and not to 
thymidine (Figure A.11) suggested the possibility that steric hindrance by the C-5 methyl group 
might be preventing η2 coordination.128    Therefore the effects of C-5 substituents on uracil’s 
and uridine’s ability to participate in η2 coordination through C-5 C-6 to [RuII(hedta)]- were 
studied. η2 coordination was observed for uracil and uridine derivatives with electron 
withdrawing substituents at C-5, but not for derivatives with electron donating substituents such 
as a methyl group.129 It was concluded that electronic factors are more important than steric 
factors. And that substituents at C-5 on thymidine don’t necessarily preclude the possibility of an 
η2 interaction with [RuII(hedta)]-.   Since the C-5 C-6 portion of C and T base residues of DNA 
reside in the major groove, an additional mode of DNA metallation seemed possible.  
The propensity for ruthenium polyaminocarboxylate ligands to coordinate in an η2 
fashion to pyrimidine and pyrimidine derivatives was investigated. At pH 7 three isomers of 
[Ru(Hedta)L]− form three isomeric complexes with pyrimidine, 4-methylpyrimidine and 2-
aminopyrimidine and five isomers with 4-aminopyrimidine.130                                  
              As previously mentioned and illustrated above, if a competing coordination site is 
available, coordination will occur there rather than at the olefinic site. However, migration from 
an N-bound site to an η2 site is possible. The capacity of [RuII(hedta)]− to migrate from N-1 of 
pyrimidine to the η2 position was observed.  Another promising observation was that the exo 
carbonyl groups on nucleobases such as uracil ad cytosine enhance the stability η2 ruthenium 
polymaminocarboxylates131    
Results from the pyrimidine experiments prompted an interest in the tendency of 
[RuII(hedta)]− to form η2 complexes with pyridazine (Figure A.12).   The σ-basicity and 
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resonance energy of pyridazine closely match those of pyrimidine. However, due to the electron 
withdrawing nature of the adjacent nitrogen atom ortho to the coordination site, pyridazine is a 
better π-acceptor.  In agreement with the fact that pyridazine is a better π-acceptor, the complex 
[RuII(hedta)(pyd)2]− exhibits a stronger bond to ruthenium than does the analogous pyrimidine 
complex. The greater π-acceptor character creates a higher barrier for migration from a nitrogen 
lone pair to an η2 site.  In fact, no η2 bound [RuII(hedta)(pyd)2]− species were observed.132 
 
 
N
N
1
2
3
4
5
6
 
                                                           Figure A.12- Pyridazine 
 
An examination of steric an electronic influences on the formation constants of sixteen 
[RuII(hedta)]- η2 complexes of olefins and pyrimidines related to cytidine and uridine led to 
several conclusions, four of which are listed here. First, η2 coordination is controlled more by 
electronic factors than by steric factors. Second, the three stereochemical isomers of RuII(hedta)- 
can determine, on the basis of size, which olefinic units may coordinate to each isomer.  For 
example, the most crowded [RuII(hedta)]- isomer will bind only to the smallest olefins.  Third, 
since some olefins can bind all three [RuII(hedta)]- isomers while others can’t, it is difficult to get 
a good estimate of binding constants.  Fourth, the sensitivity of the formation constant to ligand 
geometry, substituents, solvent, and the stereochemical isomers adopted by the metal center 
suggests that RuII agents can be tuned to form η2 complexes with cytosine and thymine.133    
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In a related project the ruthenium(II) polyaminocarboxylate, Me2-edda (Me2-edda2- = 
N,N′-dimethylethylenediaminediacetate), a derivative of [RuII(hedta)]- was prepared. [RuII(Me2-
edda)(H2O)2] exhibits axial binding sites, in contrast with the [RuII(hedta)]- complex which 
exhibits equatorial N trans bonding in the two isomers that bind to nucleobases.  The axial 
binding sites [RuII(Me2-edda)(H2O)2] present the same steric conditions as the most sterically 
hindered [RuII(hedta)]- that only binds to small substrates.  It was thought that the enhanced π-
donating capacity of [RuII(edda)] to might allow facile axial η2 coordination with DNA 
nucleobases. For [RuII(Me2-edda)(H2O)2], however, the glycinato rings migrate into axial 
positions. It was found that, like the sterically hindered [RuII(hedta)]- isomer, [RuII(Me2-
edda)(H2O)2] will not bind to pyrimidines and is selective for unhindered olefins.  The new 
feature exhibited by [RuII(Me2-edda)(H2O)2] is that bidentate dienes can promote isomerization 
into transaxial geometry which allows for η4 coordination of olefins.134  
An attempt to obtain η2-coordination between [RuII(hedta)]− and pyrazine was 
complicated by protonation of the pyrazine nitrogen atoms.   Three [RuII(hedta)(pz)]− species 
were detected, one with N-1 coordination, the other two with  η2-coordination.135 To simplify the 
system the reaction was attempted with 2,3-dimethylpyrazine.  It was hoped that steric 
conditions would force the formation of one η2 isomer.  In fact, two η2 isomers were observed in 
very low abundance with respect to the pyrazinium ligand.  The important result from this study 
was the observation of the binuclear [RuII(hedta)]2-(2,3-Me2pz)]2− complex in which the RuII 
centers exhibit non-equivalent coordination to the dimethylpyrazine bridging ligand.136 
 From the many literature reports on the capacity for RuII and OsII to disrupt aromaticity 
and to bind to olefins, some criteria had become accepted as verification that an η-2 olefinic 
complex had been formed.  Upfield shifts of 1.0-2.0 ppm for protons and 40-80 ppm for carbons 
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were accepted as evidence for the formation of an OsII or an RuII η-2 olefin.  Data were presented 
in 1996 to show that an overlooked influence on the 1H chemical shift is the adjacent ring 
structure units when the RuII  complex is [RuII(hedta)]−.  The 1H NMR chemical shifts of N-
heterocycles coordinated to d6 metals had been rationalized by magnetic anisotropy, TIP, and π-
back donation, among other effects based upon data from [Os(NH3)5]2+ complexes and a limited 
number of RuII complexes.137   In a paper regarding the effect of net charge and π-back bonding 
on the 1H NMR chemical shifts of N-heterocycles coordinated to M(NH3)5 (M = RuII, OsII, CoIII 
and RhIII) and M(CN)5n− (M = CoIII, RuII, and FeII) and RuII polyaminocarboxylates it was shown 
that the charge of the coordinating metal moiety also exerts a strong influence on the 1H NMR 
chemical shifts of  N-heterocycles coordinated to d6 metals. α protons were seen to exhibit a 
downfield shift and β protons an upfield shift with an anionic ML5 complexes; the opposite was 
observed for cationic ML5 complexes.138  The metal pentacarbonyl series [M(CO)5L] (M= Cr, 
Mo, W) was studied in C6D6 and CDCl3 to observe solvent effects and the shift pattern with 
when ML5L′ is neutral.139  
With the chemical shift variations that occur upon coordination N heterocycles to 
W(CO)5 understood, the coordination sites preferred by W(CO)5 were investigated. Photolysis of 
W(CO)6 in dry acetone in the presence of guanosine (Figure A.13) and adenosine (Figure A.14) 
promotes coordination at N-7, N-1 and N-3.   In support of similar results obtained  with 
[RuII(edta)(5′-GMP)]4− and discussed later, these results suggest that softer metal centers can 
bind to more nucleobase sites on than can the harder PtII complexes.  The presence of multiple 
binding sites on guanosine and adenosine makes W(CO)5 a viable candidate for heavy atom 
labeling of DNA. W(CO)5 coordinates only at N-3 on cytidine (Figure A.10).  Remarkably, 
W(CO)5 attacks the ribose moiety at C-3′ to form a carbene instead a pyrimidine site on 
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thymidine (Figure A.11) or uridine (Figure A.15).  Carbene formation occurs because thymidine 
and uridine lack suitable alternative binding sites.140 The carbene forming reaction was used to 
form a W(CO)5-furanosylidene complex from ribose.141  
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Figure A.13-Guanosine 
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Figure A.14-Adenosine 
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Figure A.15- Uridine 
 
To determine the factors that guide the preference of W(CO)5 for various coordination 
sites, 2-aminopyrimidine (2-ampym) and 4-aminopyrimidine (4-ampym), 2-aminopyridine (2-
ampy), 4-aminopyridine, (4-ampy) and 4-dimethylaminopyridine were used to model 
coordination to the exo-amine or the endocyclic imino nitrogen of nucleobases. Non-labile 
coordination of 2-ampym and 4-ampym to W(CO)5 through the exo-amine was observed. 
Secondary photoproducts of the 4-ampym complex were coordinated to W(CO)5 either at N-1 or 
chelated via N-3 and the exocyclic amine.  In agreement with a study completed by 
Darensbourg, 100 % of 2-aminopyridine coordinated to W(CO)5 through the pyridine nitrogen 
and coordination by 4-aminopyridine through either the exo-amine or the pyridine nitrogen.142 
New information from this study was that 4-dimethylaminopyridine coordinates to W(CO)5 
exclusively by the exo-amine.  Coordination to the exo-amine was favored by increasing its 
basicity, either by methylation or by placing it para to the pyridine nitrogen as in 4-ampym.  
Exo-amine coordination can also be favored by decreasing the basicity of the endocyclic imine.  
For example, the endocyclic nitrogens of  2-ampym and of 4-ampym are less basic that the 
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endocylic nitrogens on 2-ampy and 4-ampy.143-146  Thus there is 100% coordination at the 
endocyclic pyridine of 2-ampy and 100% at the exocyclic nitrogen of 2-ampym.147   
To test the validity of generalizing these observations, the reaction of W(CO) 5 with 4-
dimethylaminopyridine (4-Me2-ampy), 4-acetaminodpyridine (4-Acampy), 2-(methylamino) 
pyridine (2-Me-ampy) 2-(dimethylamino) pyridine (2-Me2-ampy), adenosine (A) (Figure A.16), 
N6-methyladenosine (N6-Meado), and N6,N6-dimethyladenosine (Figure A.17) was investigated.  
The 2-ampy ligand coordinated to W(CO)6 only through the pyridine nitrogen.  Introduction of 
one methyl group on the amine substituent induced coordination at both the pyridine nitrogen 
and the amino nitrogen for 2-Me-ampy.  Addition of another methyl substituent to the exo-
nitrogen forced coordination exclusively at the amino nitrogen as it did for the 4-Me2-ampy 
complex with W(CO)5.  It was thought that acetylation of the amino nitrogen on 4-aminopyridine 
would decrease the nitrogen atom’s basicity and force coordination at the pyridine nitrogen.  
Instead, the amido lone pair increased the basicity of the carbonyl oxygen to such that the 
oxygen atom, rather than the pyridine nitrogen, coordinated to the W(CO)5.148   
Amino nitrogen coordination was observed neither for N6-Meado nor for N6,N6-Meado.  
Instead, N-1 coordinates to W(CO)5 albeit to a lesser extent in N6,N6-Meado and in N6-Meado 
than in unsubstituted adenosine. The amino electrons of adensosine, N6-methyladenosine, and 
N6,N6-dimethyladenosine are too involved in resonance with the purine ring to allow the exo-
nitrogen to coordinate the W(CO)5.  Rather than increasing the basicity of the amino nitrogen, 
the methyl substituent(s) enhanced the hydrogen bonding capacity of N-3 with the ribose –OH 
group.    The enhanced hydrogen bonding blocks coordination at N-3. N-7 and N-1, are also 
blocked by the methyl group(s), thus less N-1 coordination to W(CO)5, is observed for N6,N6-
Meado than for N6-Meado.  The conclusion was that, while the aminopyridine models do not 
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mimic the coordination behavior of nucleobases, exactly, comparison of their behavior and 
structural differences reveals important aspects of nucleobase coordination to transition metal 
complexes.149 
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Figure A.16-2- and 4-Aminoyridine Derivatives and 4-Acetamidopyridine 
 
 
 
 121 
NN
N
N
N
O
OH
HH
HH
OH
HO
6
1
2
3
4
5
7
9
1'
2'3'
4'
5'
8
R R'
 
 
Figure A.17-N6-methyladenosine (R=Me; R′=H); N6, N6-dimethyladenosine (R=R′=Me) 
 
The reaction between [RuII(hedta)]− and 6-azauridine (Figure A.18) a leukemia drug and 
tumor inhibitor, also provided some interesting NMR data.  The [RuII(hedta)]− moiety was shown 
to migrate among the three binding sites of 6-azauridine, the monodentate site at N-6, the 
bidentate site at N-3 and O-4 and the η2 site between N-6 and C-5.  This was the first good 
example of RuII η2-N=CH- coordination. 13C resonances for bound olefins usually shift upfield 
40 to 80 ppm upon η2 coordination.  However, no shift in the 13C resonance for C-5 was 
observed. Two possible explanations were presented.  If olefinic π* orbitals are closer in energy 
to the RuII dπ orbital than imine π* orbitals are, then the imine 13C chemical shift should be less 
affected by η2 coordination.  Another possibility is that the electronegative nitrogen is attracted 
to RuII to the extent that RuII begins to behave like RuIII.  The strong ionic attraction cause the 
ruthenium to reside closer to nitrogen than to carbon in the -N=CH- unit, thus decrease 
backbonding to C-5.150  This unusual lack of 13C chemical shift upon η2 coordination prompted a 
follow-up experiment in which the η2 isomer was isolated in quantitative yield below pH  3.0.151  
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Figure A.18-6-azauridine 
 
Electron transfer mechanisms and redox processes were of interest because of their 
relevance to biochemistry. In unpublished work, a stable RuII center was locked into a 
[(CN)5RuIILRuIIIL′] environment to show that lowering the potential energy well on one side of a 
binuclear complex results in a loss of the intervalence band.27    
In published work it was reported that geometrical transformations change can trigger 
intramolecular electron transfer.   Oxo-bridged binuclear ions containing V(III) or V(IV) at one 
metal site and Ru(II), Ti(III) or V(II) the reducing site were studied.152-156  Some of the first 
major applications of EPR based spin trapping techniques to inorganic mechanistic studies157-161 
were reported.   Secondary ligand effects on electron transfer and the intervalence transition 
band161-163 were studied. The effects of changes in conjugation of the bridging ligand on metal 
coupling were also invstigated.90   
Metal centers bound to a tethering backbone and bridged by a small molecule mimic 
nonheme iron mixed oxidation state species.164  An iron group mixed oxidation state assembly to 
mimic the hydroxyl bridged FeIIFeIII acid phosphatase enzyme165,166 was developed.  Research on 
the reduction of O2 and H2O2 by [RuII(NH3)6]2+, [RuII(NH3)5OH2]2+, and   [RuII(NH3)5(1-
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CH3imH)]2+ 167 as well as by [(CN)5FeII(imz)]3- complexes168 was completed.  Binuclear VIII and 
FeII complexes were also prepared as models for metalloenzymes that reduce O2 and H2O2.  The 
reductions occur through O2 coordination and cooperative reduction by the metal sites without 
the release of oxygen free radicals. The crystal structure of a novel seven coordinate alkoxy 
bridged binuclear VIII complex is shown in Figure A.19. The monomer-dimer equilibrium for the 
species was also studied.169,170 For the reduction of O2 by [Fe2II(ttha)(H2O)2]2- (ttha6− = 
triethylenetetraaminehexaacetate), evidence for reduction two-electron pathway via ferryl 
intermediates was presented. 171    
 
 
 
Figure A.19-Crystal Structure of [enH2][V(hedta-H)]2•2H2O 
Reprinted with permission from J. Am. Chem Soc., 1981, 103, 5511.  Copyright 1981, American Chemical 
Society. 
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[RuIII(hedta)] and [RuIII((CH3)2edda)]+ complexes were developed as epoxidation 
catalysts using t-butyl peroxide172 and as oxidizing agents for alcohols bearing an α proton.173  A 
review of ruthenium-oxo catalysts for stilbene oxidation was presented and explained how one 
could predict which catalysts would epoxidize with retention of configuration.174 Formation of  
[Ti(O2)(edta)]2- by peroxo displacement of  the oxo moiety in [TiO(edta)]2- and by reduction of a 
superoxo transient [Ti(O2)(edta)]− 175,176 was reported.  The crystal structure of [Ti(edta)(H2O)] 
(Figure A. 20) revealed that at low pH the Ti(IV)-edta4− complex has an axial H2O rather than an 
oxo group as previously believed.  At higher pH the H2O is deprotonated to form the π-donating 
oxo group.177   
 
 
Figure A.20-Crystal Structure of [Ti(edta)(H2O)] 
Reprinted with permission from J. Am. Chem Soc., 1985, 24, 1857.  Copyright 1985, American Chemical 
Society. 
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The chemistry and redox reactions of [Ru(CN)5]3+(II) complexes of several aromatic 
nitrogen heterocycles were developed.178,179  The alcohol functionality of N-
hydroxyethylethylenediaminetriacetate, which had been considered to be an innocent ligand was 
shown to accelerate ligand substitution reaction for [CrIII(hedta)].180,181  
In collaboration with Professor Paul Dowd, the one electron reduction potentials of 
coenzyme B12 and alkyl cobalamins were measured.  These results, along with literature 
molecular orbital treatments, suggest that the reduction potential varies with the energy of the 
lowest unfilled molecular orbital (the cobalt dz2* and the alkyl σ) and with Co-C distance.182,183   
In 1987 development of complexes for antitumor use and for the control of free radical 
cell damage was begun.  In collaboration with Thomas J. Lomis and Jerome F. Suida, the 
preparation of the dioxygen-activating metal head group analogue of the antitumor drug 
bleomycin, [Fe(HAPH)] (HAPH = N-[2-(imidazol-3-yl)ethyl-6-{[(2-(imidazol-3-
yl)ethyl]amino}methyl]-2-pyridinecarboxamide) (Figure A.21) was reported. An axial imidazole 
in HAPH replaces the axial amine donor in bleomycin.  A sulfur analogue which was also 
prepared [FeII(SAPH)] (SAPH =2-pyridinecarboxamide,N-[2-(1H-imidazol-4-yl)ethyl]-6-[[[2-
(methylthio)ethyl]amino]methyl]) (Figure A.22) did not cleave DNA.184,185  [FeII(HAPH)], 
however, even lacking the recognition tail of bleomycin, is approximately half as efficient as 
bleomycin at cleaving DNA and operates through the same ferryl pathway as bleomycin.186  The 
[CuII(HAPH)] complex was found to behave the same as [FeII(HAPH)]. 187 An X-ray crystal 
structure obtained for the CuII salt, [CuII(HAPH)]ClO4 (Figure A.23) revealed that the imidazole 
moiety of HAPH binds in the axial position.188  Much of the early imidazole and redox research 
laid the foundation for these bleomycin studies and for a review on O2 activation by 
polyaminocarboxylates and imidazole based complexes.189 A review was also prepared on the 
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use of Ru(II)-polyamniocarboxylate complexes for improved DNA probes for the American 
Chemical Society’s Advances in Chemistry Series.190   
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Figure A.21- HAPH Ligand 
N-(2-(imidazol-3-yl)ethyl-6-(((2-(imidazol-3-yl)ethyl)amino)methyl)-2-pyridinecarboxamide  
Reprinted from Inorganica Chimica Acta,  171  “The crystal structure of [Cu(HAPH)]ClO4.1.6H2O and the 
cleavage of DNA by analogs of the metal binding core of bleomycin” 139-149, Copyright Elsevier, 1990. 
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Figure A.22- SAPH Ligand 
2-pyridinecarboxamide,N-[2-(1H-imidazol-4-yl)ethyl]-6-[[[2-(methylthio)ethyl]amino]methyl] 
Reprinted from Inorganica Chimica Acta,  171  “The crystal structure of [Cu(HAPH)]ClO4.1.6H2O and the 
cleavage of DNA by analogs of the metal binding core of bleomycin” 139-149, Copyright Elsevier, 1990. 
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Figure A.23-ORTEP diagram of [Cu(HAPH)]+ 
Reprinted from Inorganica Chimica Acta,  171  “The crystal structure of [Cu(HAPH)]ClO4.1.6H2O and the 
cleavage of DNA by analogs of the metal binding core of bleomycin” 139-149, Copyright Elsevier, 1990. 
 
In collaboration with Yisrael Isaccson, spin trapping was used  to show that lactobionic 
acid, an active ingredient of transplant organ preservative, may prevent oxidation of free FeII and 
FeIII  by O2 and H2O2 by forming [FeIII(lactobionate)].191,192 
Early work on the illustrated the additivity effects of ligands when VIV is used as a 
metalloenzyme in EPR studies.193  Later the additivty effects were applied to show that the 
number of imidazole/histidyl units on a metalloenzyme may be estimated from comparison of 
the enzyme’s EPR N-hyperfine structure to that of library spectra.194 
Results from dearomatization of pyrimidine and DNA bases by RuII 
polyaminocarboxylates as described earlier were applied to designing RuII based antitumor 
agents that might attack different tumor lines that those attacked by the PtII agents in use.128,131,133  
A model for anchoring two RuII headgroups via pyrimidine base coordination was produced 
from dimethyluracil (Figure A.8).  The methyl groups of dimethyl uracil prevent N-1 and N-3 in 
the same manner as N-3 coordination to pyrimidine bases is obstructed  by hydrogen bonding to 
a purine base of DNA.127  The ruthenium(II) polyaminocarboxylate, [RuII(hedta)]− was shown to 
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bind at the normal N-3 position of uridine (Figure A.15) and cytidine bases  (Figure A.10) or to 
bind in an η2 fashion through the C-5 C-6 olefinic site.131  Further evidence for η2-coordination 
was provided by the preparation and characterization of bis-[Ru(hedta)(pym)2]−  which exhibits 
one stereochemically-rigid η2-bound pyrimidine and one fluxional N-bound pyrimidine. 195 
Platinum complexes with geometries other than the usual square planar geometry 
exhibited by most PtII complexes are of interest for their antitumor properties and for DNA 
labeling. The geometry variation may allow the complex to react more rapidly with or may select 
different base pairs along the DNA strand.  Experiments with polyaminocarboxylates revealed 
their capacity to force PtII into 5-coorination. In particular the 2-pyridine-2-
methylaminiediacetate ligand (pida2-) was shown to react with  K2PtCl4  to form a five-
coordinate trigonal bipyramidal complex.196  Formation of the five-coordinate [Pt(uedda)Cl]− and 
[Pt(uedda)(H2O)] upon reaction of K2PtCl4 with N,N-ethylenediaminediacetate (uedda) suggests 
that five coordinate PtII species may be more common with chelate ligands than has been 
realized.  Similar observations were made for the reaction between nitrilotriacetic acid and 
K2PtCl4 Five coordindate PtII complexes are much like the well accepted stabilized five-
coordinate intermediates that form during ligand substitution reactions.197  A 
polyaminocarboxylate that can hold a potentially chelating ligand  near the same site used during 
substitution it is likely to be more stable than the intermediate that forms during substitution.198   
Hetero- and homo-binuclear complexes were also of interest. In 1979 the first FeII/III-
imidazolato-CuI/II bridged complexes which were models for complexes believed to be 
responsible for the magnetic coupling and electron transfer between heme iron and copper 
centers of cytochrome oxidase were prepared. The complexes [(CH3CN)(TIM)Fe(imep)Cu]3+ 
(TIM =2,3,9,10-tetramethyl-1,4,8,11-tetraazacyclotetradeca-1,3,8,10-tetraene; impeH = 2-[2-(4-
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imidazolyl)ethyliminomethyl]-pyridine) and [(CH3CN)(TIM)Fe(bidH)Cu]3+ (bidH2 = 2,3-bis(4-
ethylimidazolyl)butanediimine) are shown in figures A.24   and  A.25, respectively.199  
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Figure A.24-[(CH3CN)(TIM)Fe(imep)Cu]3+ 
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Figure A.25-[(CH3CN)(TIM)Fe(bidH)Cu]3+
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 Later the species responsible for magnetic coupling and electron transfer between heme 
iron and copper centers of cytochrome oxidase was shown to be a metal oxo chromophore. 
Models of the metal-oxo chromophore were prepared from the polyaminocarboxylate ligand, 
triethylenetetramininehexaacetate (ttha6−).166 Homo- and hetero-binuclear 
polyaminocarboxylates were also of interest for their potential to form PdII and PtII major groove-
spanning chelates and act as cisplatin alternatives.  The reactivity of a cis(R,S)-[Pd(egta)]2−  
(egta4− = glycine, N,N′-(1,2-ethanediylbis(oxy-2,1-ethanediyl)bis[N-carboxymethyl])) complex 
with CdII was studied in an attempt to synthesize the heteronuclear CdII-PdII complex, 
[Cd(Pd)(egta)].  No [Cd(Pd)(egta)] was observed, although its existence as an intermediate was 
required to account for the observed [Pd2(egta)Cl2]2− product.200 The CdII-PdII intermediate is 
bound by two pendant carboxylates. The 1:1 complex,  cis(R,S)-[Pd(egta)]2− was shown to 
exhibit a temperature-dependent dynamic rearrangement which proceeds via five coordinate 
intermediates in aqueous solution.201  Detailed 1H, 13C, and 15N NMR studies were carried out on 
cis(R,S)-[Pd(egta)]2− and on [Pd2(egta)Cl2]2−.202   
The effect of ZnII on the formation of  2,2′- and 2,3′-bipyridine complexes of 
[RuII2(ttha)]2− (ttha6− = triethylenetetraminehexaacetate) was shown to be similar to that of  CdII  
on cis(R,S)-[Pd(egta)]2− in that 2,2′-bipyridine displaces one in-plane glycinato donor per RuII 
which form a tight ion pair with Zn(H2O)62+.   However, due to the strong RuII-N bonds as 
compared to the PdII-N bonds, the addition sequence for [Ru2(ttha)(H2O)2]2−/2,2′-bpy system is 
more complicated than that for the CdII/[Pd(egta)]2− reaction.203   
Binuclear PtII complexes with metal binding sites connected by an organic tether form 
interstrand cross-links through N-7 attachments at GC sequences in DNA.  Such cross-links may 
inhibit regulatory and repair proteins from reaching to the major groove of DNA. Displacement 
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of one chloride in [Pt2(hdta)Cl2]2− (hdta4− = 1,6-hexanediamine-N,N,N′,N′ -tetraacetate) by 
inosine to form [Pt2(hdta)Cl(ino)]− occurs 3.4 times faster than DNA displacement of a chloride 
ion from cisplatin. The structures of [Pt2(hdta)Cl2]2− and inosine and the product, 
[Pt2(hdta)Cl(ino)]− are shown in figures A.26, A.27 and A.28, respectively.  Inosine, a purine 
base that lacks the 2 amino group of guanosine, is used as a representative purine base for 
reactions with PtII and PdII complexes because of its solubility.204 In a later paper the crystal 
structure of [MV][Pt2(hdta)Cl2]•4H2O (MV =1,1′-dimethyl-4,4′-bipyridinium) was reported 
along with the formation the tetrasubstituted [Pt2(hdta)(Ino)4].  The PdII binuclear analogue of 
[Pt2(hdta)Cl2]2− and the heterobinuclear [PdII(hdta)(H2O)PtIICl(hdta)]− were later characterized 
by 13C and 1H NMR spectroscopy. Formation of  [PdII(hdta)(H2O)PtIICl(hdta)]− suggests that 
other hybrids can be formed from [PdII(hdta)]2− and [PtII(hdta)]2−. Only the formation of the 
mononuclear complex [PdII(dhpta)]2− (dhpta4− = 1,3-diamino-2-hydroxypropane-N,N,N′,N′-
tertraacetate) was observed under conditions in which the [Pt2(hdta)Cl2]2− forms quickly. 
Formation of only the mononuclear [PdII(dhpta)]2− complex was attributed to the fact that there 
are only three linker units in dhpta4− as opposed to six linkers in hdta4−.205   
A mechanistic study of the substitution of inosine on [Pd(mida)Cl]−, [Pd(mida)(D2O)2], 
[Pd(egta)(D2O)2] and of guanosine 5′-monophosphate (5′-GMP) on [Pd2(egta)(D2O)2] 
highlighted some of the differences between the chemistry of PdII and PtII.206 N-3 and N-7 
coordinated [RuII(edta)(5′-GMP)]4− complexes were studied in collaboration with Debabrata 
Chatterjee.  The N-3 site of 5′-GMP-H is in the minor groove when GMP is incorporated into 
DNA.  Coordination at N-3 suggests that soft donors might preferentially seek N-3 rather than N-
7 which projects into the major groove.207   
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Figure A.26-[Pt2II(hdta)Cl2]2− 
Reprinted with permission from Inorganica Chimca Acta, 271, Lin Fu-Tyan, Shepherd, Rex E. Substitution 
of inosine for chloride in [Pt2(hdta)Cl2]2- (hdta4- = 1,6-hexanediamine-N,N,N',N'-tetraacetate) 124-128, copyright 
Elsevier. 
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Figure A.27-Inosine 
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Figure A.28- [Pt2(hdta)Cl(ino)]− 
The polyaminocarboxylate N,N′-bis-(pyridylmethyl)ethylenediamine-N,N′-diacetate 
(edampda2−) ligand (Figure A.29) was used in the development of the nitric oxide scavenger 
[FeII(edampda)(H2O)]. The edampda2− ligand is a derivative of edta4− in which two carboxylate 
groups have been replaced by pyridyl groups.  The pyridyl groups increase the ligand field 
strength with respect to edta4−.  The stronger ligand field strength is evidenced by the spin state 
character of a series of polyaminocarboxylate complexes of FeIINO.  [Fe(edta)(NO)]2− 208,209 the 
weakest field of the series exhibits S=3/2. The [Fe(edampda)(NO)] exhibits spin crossover 
behavior.210 Finally, [Fe(tpen)(NO)]2+ (tpen = N,N,N′,N′-tetrakis(2-
pyridylmethyl)ethylenediamine), which has the strongest ligand field  exhibits S = 1/2.211  See  
Figure A.30 for the structure of tpen. The solution behavior of [CuII(edampda)] and 
[ZnII(edampda)] was also investigated.212    
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Figure A.29-N,N′-bis-(pyridylmethyl)ethylenediamine-N,N′-diacetate 
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Figure A.30-N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine 
 
Two ligands related to edampda, 2,2′-dipyridyl amine (dpaH) shown in Figure A.31 and 
N,N,N′,N′-tetrakis(2-pyridyl)adipamide (tpada) shown in Figure A.32  were studied.   At the time 
this work was published there were few reports of dpaH complexes of PtII, PdII and RuII.  Some 
of the few that had been synthesized exhibited and antitumor activity comparable to 
cisplatin.213,214  PtII, PdII and RuII complexes of the  tpada ligand might serve as a crosslinker 
toward DNA.  [RuII(hedta)]− complexes with dpaH and tpada allowed their π-acceptor ability to 
be determined as bpy > 1/2tpada > dpaH  > dpa−.  Further studies with tpada as a multidentate 
chelate toward one metal center such as CuII, NiII, FeII, or RuII with and NO or CO ligand in an 
were in development as antitumor agents.215   
 FeII aminocarboxylate and pyridyl based complexes were also developed for use 
as NO scavengers.  The ttha ligand (ttha6− = triethyenetetraminehexaacetate) forms the binuclear 
[Ru2III(ttha)(H2O)2] complex which reacts readily with NO to form [(RuII(NO+))2(ttha)].  The 
asymmetric mononitrosyl derviative [(Ru2II(NO+)(bpy)(ttha)]2− has potential to bind to DNA.216 
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While the complexes do bind NO their reactivity to oxygen limits their use as NO scavengers in 
blood.  The TIM ligand (TIM = 2,3,9,20-tetrmethyl-1,4,8,11-tetraazacyclodeca-1,3,8,10-
tetraene)  is a water soluble unsaturated macrocycle similar to porphyrins.  The reversible 
coordination of NO to [Fe(TIM)(CH3CN)2]2+ was found to be similar to FeIIporphyrin  
nitrosyls.217 
The first reported set of NO+, NO, and NO− complexes for the same metal center in same 
oxidation state and a constant ligand environment was prepared from RuII and hedta3−.  The NO 
complex exists as cis- and trans-equatorial isomers which have 15N NMR resonances at 609.4 
and 607.4 ppm, respectively.  That these singlet NO− complexes absorb in the infrared at 1383 
cm−1 suggests that there is some backbonding from RuII.  Typically NO− absorbs around 1650 
cm−1.  The NO+ complex  which exists as the cis-equatorial species absorbs in the infrared at 
1846 cm−1  and exhibits a resonance at 249.6 ppm in its 15N NMR spectrum.  The NO• complex 
has an infrared absorbance at 1858 cm−1.  The lower stretching frequency for NO+ than for NO• 
indicates that there is more RuII to NO + than for NO•.  A molecular orbital analysis was 
presented to rationalize the existence of singlet as well as triplet NO.  Whether NO− is singlet or 
triplet depends upon the energy of orbitals with respect to the energy of the dz2 and dx2-y2 orbitals. 
If the π* NO orbitals are lower in energy than the metal dz2 and dx2-y2 orbitals as they are with  
RuII in this case, then singlet NO− is favored. The lower charge of [Ru(hedta)(NO+)] compared to 
[Ru(edta)(NO+)]− may allow more facile biological transport.  Related mixed pyridyl, mixed 
carboxylate ligands were studied.14 
Studies of binuclear complexes which have applications to electron transfer reactions as 
well as medicinal applications were continued.  The mixed-valence RuIV-FeII complex 
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[RuIV(edtaH)(NC)FeII)(CN)5]4−, analogous to Taube’s [RuIV(NH3)5(NC)FeII)(CN)5] complex, 
was prepared and characterized in collaboration with Debabrata Chatterjee.218   
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Figure A.31-2,2′-dipyridylamine (dpaH) 
 
 
N
N
N
N
N
N
O
O
 
 
Figure A.32-N,N,N′,N′tetrakis(2-pyridyl)adipamide (tpada) 
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